4-hydroxybenzoate ester - Ontology Report - Rat Genome Database

Submit Data | Help | Video Tutorials | News | Publications | Download | REST API | Citing RGD | Contact

Advanced Search (OLGA)

CHEBI ONTOLOGY - ANNOTATIONS

{{ watchLinkText }}

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.

Term:	4-hydroxybenzoate ester	go back to main search page
Accession:	CHEBI:79323	browse the term
Definition:	A benzoate ester that is an ester of 4-hydroxybenzoic acid.
Synonyms:	related_synonym:	4-hydroxybenzoate esters; Formula=C7H5O3R; SMILES=Oc1ccc(cc1)C(=O)O[*]; p-hydroxybenzoate ester; p-hydroxybenzoate esters

show annotations for term's descendants Sort by:
Rat (1447) Mouse (1459) Human (1685) Chinchilla (0) Bonobo (0) Dog (0) Squirrel (0) Pig (0) Green Monkey (0) Naked Mole-rat (0) All
Genes (1447)

ethylparaben

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

arylacetamide deacetylase-like 3

increases expression

ethyl-p-hydroxybenzoate results in increased expression of AADACL3 mRNA

NCBI chr 5:156,242,182...156,252,215
Ensembl chr 5:156,243,415...156,252,205

G

apoptosis-associated tyrosine kinase

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of AATK mRNA

NCBI chr10:105,290,752...105,327,219
Ensembl chr10:105,291,585...105,327,112

G

ATP binding cassette subfamily A member 3

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of ABCA3 mRNA

NCBI chr10:13,382,439...13,439,748
Ensembl chr10:13,382,540...13,439,745

G

ATP binding cassette subfamily C member 8

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of ABCC8 mRNA

NCBI chr 1:96,598,568...96,679,563
Ensembl chr 1:96,598,647...96,679,510

G

ATP binding cassette subfamily D member 2

increases expression

ethyl-p-hydroxybenzoate results in increased expression of ABCD2 mRNA

NCBI chr 7:122,263,034...122,311,642
Ensembl chr 7:122,263,032...122,311,642

G

ATP binding cassette subfamily G member 4

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of ABCG4 mRNA

NCBI chr 8:44,611,187...44,629,818
Ensembl chr 8:44,611,187...44,626,881

G

abhydrolase domain containing 1

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of ABHD1 mRNA

NCBI chr 6:25,422,526...25,427,514
Ensembl chr 6:25,422,526...25,427,514

G

aggrecan

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of ACAN mRNA

NCBI chr 1:132,981,582...133,044,416
Ensembl chr 1:132,981,582...133,043,627

G

acid phosphatase 3

increases expression

ethyl-p-hydroxybenzoate results in increased expression of ACP3 mRNA

NCBI chr 8:104,905,570...104,956,146
Ensembl chr 8:104,905,586...104,954,236

G

acyl-CoA synthetase short-chain family member 1

increases expression

ethyl-p-hydroxybenzoate results in increased expression of ACSS1 mRNA

NCBI chr 3:139,450,383...139,500,325
Ensembl chr 3:139,450,383...139,500,325

G

actin-like 6B

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of ACTL6B mRNA

NCBI chr12:19,124,887...19,141,419
Ensembl chr12:19,124,916...19,141,376

G

ADAM metallopeptidase domain 33

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of ADAM33 mRNA

NCBI chr 3:118,262,395...118,283,456
Ensembl chr 3:118,271,029...118,283,461

G

ADAM metallopeptidase with thrombospondin type 1 motif, 4

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of ADAMTS4 mRNA

NCBI chr13:83,670,556...83,680,045
Ensembl chr13:83,670,183...83,680,065

G

ADAMTS-like 1

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of ADAMTSL1 mRNA

NCBI chr 5:99,964,406...100,919,786
Ensembl chr 5:99,964,486...100,918,384

G

ADAMTS-like 2

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of ADAMTSL2 mRNA

NCBI chr 3:10,397,774...10,434,557
Ensembl chr 3:10,404,626...10,434,554

G

ArfGAP with dual PH domains 1

increases expression

ethyl-p-hydroxybenzoate results in increased expression of ADAP1 mRNA

NCBI chr12:15,323,913...15,376,110
Ensembl chr12:15,324,209...15,380,831

G

adenylate cyclase 10

increases expression

ethyl-p-hydroxybenzoate results in increased expression of ADCY10 mRNA

NCBI chr13:77,747,752...77,833,952
Ensembl chr13:77,768,468...77,833,951

G

adenylate cyclase 8

increases expression

ethyl-p-hydroxybenzoate results in increased expression of ADCY8 mRNA

NCBI chr 7:96,417,310...96,665,911
Ensembl chr 7:96,417,324...96,665,911

G

adhesion G protein-coupled receptor B1

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of ADGRB1 mRNA

NCBI chr 7:106,404,827...106,476,902
Ensembl chr 7:106,404,958...106,476,902

G

adhesion G protein-coupled receptor D2

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of ADGRD2 mRNA

G

adhesion G protein-coupled receptor F1

increases expression

ethyl-p-hydroxybenzoate results in increased expression of ADGRF1 mRNA

NCBI chr 9:17,661,258...17,696,359
Ensembl chr 9:17,660,930...17,711,704

G

adhesion G protein-coupled receptor G3

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of ADGRG3 mRNA

NCBI chr19:9,972,425...10,001,118
Ensembl chr19:9,972,430...10,001,123

G

adhesion G protein-coupled receptor L4

increases expression

ethyl-p-hydroxybenzoate results in increased expression of ADGRL4 mRNA

NCBI chr 2:240,354,909...240,457,231
Ensembl chr 2:240,354,941...240,457,225

G

adiponectin, C1Q and collagen domain containing

increases expression

ethyl-p-hydroxybenzoate results in increased expression of ADIPOQ mRNA

NCBI chr11:77,721,912...77,735,644
Ensembl chr11:77,721,912...77,735,564

G

adrenoceptor alpha 1B

increases expression

ethyl-p-hydroxybenzoate results in increased expression of ADRA1B mRNA

NCBI chr10:28,255,025...28,373,418
Ensembl chr10:28,255,025...28,312,919

G

actin filament associated protein 1

increases expression

ethyl-p-hydroxybenzoate results in increased expression of AFAP1 mRNA

NCBI chr14:74,743,322...74,856,300
Ensembl chr14:74,743,320...74,856,263

G

ArfGAP with GTPase domain, ankyrin repeat and PH domain 2

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of AGAP2 mRNA

NCBI chr 7:62,897,282...62,914,295
Ensembl chr 7:62,897,282...62,914,295

G

aryl hydrocarbon receptor

increases expression

ethyl-p-hydroxybenzoate results in increased expression of AHR mRNA

NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568

G

allograft inflammatory factor 1

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of AIF1 mRNA

NCBI chr20:3,646,784...3,652,670
Ensembl chr20:3,646,777...3,652,668

G

AIF family member 3

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of AIFM3 mRNA

NCBI chr11:83,504,859...83,523,630
Ensembl chr11:83,504,861...83,521,248

G

aldo-keto reductase family 1, member C2

increases expression

ethyl-p-hydroxybenzoate results in increased expression of AKR1C2 mRNA

NCBI chr17:65,759,778...65,808,013
Ensembl chr17:65,759,788...65,775,764

G

aldo-keto reductase family 1, member C3

increases expression

ethyl-p-hydroxybenzoate results in increased expression of AKR1C3 mRNA

NCBI chr17:66,110,970...66,127,867
Ensembl chr17:66,110,963...66,127,873

G

aldehyde dehydrogenase 1 family, member A2

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of ALDH1A2 mRNA

NCBI chr 8:71,877,850...71,957,107
Ensembl chr 8:71,877,850...71,957,107

G

arachidonate 15-lipoxygenase

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of ALOX15 mRNA

NCBI chr10:55,060,169...55,068,885
Ensembl chr10:55,060,412...55,068,874

G

ALS2 C-terminal like

increases expression

ethyl-p-hydroxybenzoate results in increased expression of ALS2CL mRNA

NCBI chr 8:110,863,753...110,884,434
Ensembl chr 8:110,864,975...110,884,419

G

ameloblastin

increases expression

ethyl-p-hydroxybenzoate results in increased expression of AMBN mRNA

NCBI chr14:19,601,761...19,614,382
Ensembl chr14:19,601,702...19,614,393

G

angiopoietin 4

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of ANGPT4 mRNA

NCBI chr 3:140,420,389...140,454,213
Ensembl chr 3:140,420,389...140,453,583

G

ankyrin repeat and death domain containing 1B

increases expression

ethyl-p-hydroxybenzoate results in increased expression of ANKDD1B mRNA

NCBI chr 2:27,750,301...27,814,291
Ensembl chr 2:27,750,987...27,813,734

G

ankyrin repeat domain 24

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of ANKRD24 mRNA

NCBI chr 7:8,061,634...8,081,142
Ensembl chr 7:8,061,953...8,081,142

G

ankyrin repeat domain 53

increases expression

ethyl-p-hydroxybenzoate results in increased expression of ANKRD53 mRNA

NCBI chr 4:116,245,561...116,253,018
Ensembl chr 4:116,246,955...116,253,017

G

amyloid beta precursor protein binding family B member 1 interacting protein

increases expression

ethyl-p-hydroxybenzoate results in increased expression of APBB1IP mRNA

NCBI chr17:84,941,404...85,033,020
Ensembl chr17:84,982,243...85,033,010

G

APC regulator of WNT signaling pathway 2

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of APC2 mRNA

NCBI chr 7:9,392,336...9,414,364
Ensembl chr 7:9,392,336...9,414,310

G

apolipoprotein L2

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of APOL2 mRNA

NCBI chr 7:109,331,367...109,338,632
Ensembl chr 7:109,331,392...109,338,558

G

androgen receptor

multiple interactions

ethyl-p-hydroxybenzoate inhibits the reaction [Stanozolol binds to and results in increased activity of AR protein]

NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925

G

Rho GTPase activating protein 10

increases expression

ethyl-p-hydroxybenzoate results in increased expression of ARHGAP10 mRNA

NCBI chr19:30,448,572...30,710,315
Ensembl chr19:30,448,637...30,710,313

G

Rho GTPase activating protein 40

increases expression

ethyl-p-hydroxybenzoate results in increased expression of ARHGAP40 mRNA

NCBI chr 3:147,165,781...147,206,552
Ensembl chr 3:147,165,729...147,207,203

G

AT-rich interaction domain 3C

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of ARID3C mRNA

NCBI chr 5:56,889,649...56,896,959
Ensembl chr 5:56,890,042...56,895,888

G

armadillo repeat containing 12

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of ARMC12 mRNA

NCBI chr20:6,587,859...6,598,355
Ensembl chr20:6,587,859...6,598,352

G

arylsulfatase L

increases expression

ethyl-p-hydroxybenzoate results in increased expression of ARSL mRNA

NCBI chr 2:119,038,803...119,047,579
Ensembl chr 2:119,038,921...119,046,846

G

ATPase Na+/K+ transporting subunit alpha 3

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of ATP1A3 mRNA

NCBI chr 1:80,572,790...80,601,936
Ensembl chr 1:80,572,796...80,601,918

G

ATPase plasma membrane Ca2+ transporting 2

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of ATP2B2 mRNA

NCBI chr 4:146,894,602...147,208,060
Ensembl chr 4:146,896,332...147,140,665

G

ATPase H+/K+ transporting subunit alpha

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of ATP4A mRNA

NCBI chr 1:85,961,607...85,974,972
Ensembl chr 1:85,961,708...85,974,844

G

brain-enriched guanylate kinase-associated

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of BEGAIN mRNA

NCBI chr 6:127,943,651...127,979,876
Ensembl chr 6:127,943,651...127,979,841

G

beaded filament structural protein 1

increases expression

ethyl-p-hydroxybenzoate results in increased expression of BFSP1 mRNA

NCBI chr 3:131,195,087...131,252,668
Ensembl chr 3:131,195,087...131,229,337

G

bone gamma-carboxyglutamate protein

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of BGLAP mRNA

NCBI chr 2:173,838,518...173,839,495
Ensembl chr 2:173,838,518...173,839,495

G

betaine-homocysteine S-methyltransferase 2

increases expression

ethyl-p-hydroxybenzoate results in increased expression of BHMT2 mRNA

NCBI chr 2:24,895,525...24,912,475
Ensembl chr 2:24,895,533...24,912,475

G

BICD family like cargo adaptor 2

increases expression

ethyl-p-hydroxybenzoate results in increased expression of BICDL2 mRNA

NCBI chr10:12,691,610...12,700,049
Ensembl chr10:12,691,610...12,700,049

G

bone morphogenetic protein 3

increases expression

ethyl-p-hydroxybenzoate results in increased expression of BMP3 mRNA

NCBI chr14:10,712,489...10,737,153
Ensembl chr14:10,712,489...10,737,153

G

bone morphogenetic protein 8b

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of BMP8B mRNA

NCBI chr 5:135,386,058...135,411,337
Ensembl chr 5:135,386,311...135,405,197

G

bolA family member 2

increases expression

ethyl-p-hydroxybenzoate results in increased expression of BOLA2 mRNA

NCBI chr 1:181,291,967...181,292,833
Ensembl chr 1:181,291,398...181,292,676

G

bone marrow stromal cell antigen 1

increases expression

ethyl-p-hydroxybenzoate results in increased expression of BST1 mRNA

NCBI chr14:67,253,706...67,270,203
Ensembl chr14:67,252,998...67,270,180

G

similar to human chromosome 1 open reading frame 116

increases expression

ethyl-p-hydroxybenzoate results in increased expression of C1ORF116 mRNA

NCBI chr13:42,187,442...42,201,432
Ensembl chr13:42,188,609...42,201,426

G

simlar to human chromosome 19 open reading frame 81

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of C19ORF81 mRNA

NCBI chr 1:94,857,301...94,871,323
Ensembl chr 1:94,857,115...94,871,813

G

similar to human chromosome 19 open reading frame 85

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of C19ORF85 mRNA

NCBI chr 1:68,929,184...68,937,113
Ensembl chr 1:68,929,333...68,936,922

G

complement C1q like 1

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of C1QL1 mRNA

NCBI chr10:87,902,125...87,909,556
Ensembl chr10:87,902,137...87,909,310

G

complement C1q like 4

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of C1QL4 mRNA

NCBI chr 7:130,243,606...130,246,678
Ensembl chr 7:130,243,606...130,246,678

G

similar to human chromosome 10 open reading frame 105

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of C10ORF105 mRNA

NCBI chr20:28,333,094...28,339,341
Ensembl chr20:28,336,101...28,336,487

G

similar to human chromosome 6 open reading frame 15

increases expression

ethyl-p-hydroxybenzoate results in increased expression of C6ORF15 mRNA

NCBI chr20:3,172,330...3,173,886
Ensembl chr20:3,172,330...3,173,886

G

C2 calcium-dependent domain containing 4C

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of C2CD4C mRNA

NCBI chr 7:10,090,651...10,095,426
Ensembl chr 7:10,092,138...10,095,421

G

similar to human chromosome 1 open reading frame 127

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of C1ORF127 mRNA

NCBI chr 5:159,075,217...159,110,642
Ensembl chr 5:159,075,343...159,105,369

G

similar to human chromosome 11 open reading frame 52

increases expression

ethyl-p-hydroxybenzoate results in increased expression of C11ORF52 mRNA

NCBI chr 8:51,081,342...51,088,333
Ensembl chr 8:51,081,342...51,094,533

G

calcium binding protein 39-like

increases expression

ethyl-p-hydroxybenzoate results in increased expression of CAB39L mRNA

NCBI chr15:33,606,588...33,710,518
Ensembl chr15:33,606,694...33,743,545

G

calcium binding protein 1

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of CABP1 mRNA

NCBI chr12:41,385,234...41,448,930
Ensembl chr12:41,378,897...41,448,927

G

calcium voltage-gated channel subunit alpha1 B

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of CACNA1B mRNA

NCBI chr 3:7,380,892...7,546,104
Ensembl chr 3:7,380,922...7,546,091

G

calcium voltage-gated channel subunit alpha1 E

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of CACNA1E mRNA

NCBI chr13:66,574,659...67,063,443
Ensembl chr13:66,581,920...66,894,450

G

calcium voltage-gated channel subunit alpha1 F

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of CACNA1F mRNA

NCBI chr X:14,868,096...14,896,413
Ensembl chr X:14,868,024...14,896,413

G

calcium voltage-gated channel auxiliary subunit gamma 4

increases expression

ethyl-p-hydroxybenzoate results in increased expression of CACNG4 mRNA

NCBI chr10:92,683,778...92,745,842
Ensembl chr10:92,683,761...92,746,126

G

calcium voltage-gated channel auxiliary subunit gamma 7

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of CACNG7 mRNA

NCBI chr 1:65,800,059...65,831,246
Ensembl chr 1:65,800,355...65,831,006

G

calbindin 2

increases expression

ethyl-p-hydroxybenzoate results in increased expression of CALB2 mRNA

NCBI chr19:38,114,435...38,141,438
Ensembl chr19:38,114,424...38,141,438

G

calcium homeostasis modulator family member 5

increases expression

ethyl-p-hydroxybenzoate results in increased expression of CALHM5 mRNA

NCBI chr20:26,066,270...26,072,348
Ensembl chr20:26,066,242...26,072,272

G

calcyon neuron-specific vesicular protein

increases expression

ethyl-p-hydroxybenzoate results in increased expression of CALY mRNA

NCBI chr 1:194,862,671...194,873,861
Ensembl chr 1:194,862,672...194,873,551

G

carbonic anhydrase 8

increases expression

ethyl-p-hydroxybenzoate results in increased expression of CA8 mRNA

NCBI chr 5:21,302,940...21,402,395
Ensembl chr 5:21,305,383...21,402,374

G

caspase recruitment domain family, member 11

increases expression

ethyl-p-hydroxybenzoate results in increased expression of CARD11 mRNA

NCBI chr12:13,621,140...13,758,115
Ensembl chr12:13,621,087...13,758,112

G

capping protein regulator and myosin 1 linker 3

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of CARMIL3 mRNA

NCBI chr15:28,978,440...28,995,865
Ensembl chr15:28,979,007...28,996,225

G

cation channel, sperm associated 4

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of CATSPER4 mRNA

NCBI chr 5:146,427,682...146,447,346
Ensembl chr 5:146,427,683...146,446,942

G

coiled-coil domain containing 120

increases expression

ethyl-p-hydroxybenzoate results in increased expression of CCDC120 mRNA

NCBI chr X:14,753,594...14,772,745
Ensembl chr X:14,753,696...14,772,743

G

coiled-coil domain containing 141

increases expression

ethyl-p-hydroxybenzoate results in increased expression of CCDC141 mRNA

NCBI chr 3:61,948,614...62,109,968
Ensembl chr 3:61,948,646...62,110,079

G

coiled-coil domain containing 171

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of CCDC171 mRNA

NCBI chr 5:97,919,965...98,403,853
Ensembl chr 5:97,920,002...98,282,833

G

coiled-coil domain containing 194

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of CCDC194 mRNA

NCBI chr16:18,205,099...18,209,310
Ensembl chr16:18,205,095...18,209,283

G

coiled-coil domain 39 molecular ruler complex subunit

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of CCDC39 mRNA

NCBI chr 2:116,665,651...116,703,354
Ensembl chr 2:116,665,261...116,703,350

G

coiled-coil domain containing 63

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of CCDC63 mRNA

NCBI chr12:34,424,388...34,453,080
Ensembl chr12:34,424,344...34,453,085

G

coiled-coil domain containing 68

increases expression

ethyl-p-hydroxybenzoate results in increased expression of CCDC68 mRNA

NCBI chr18:63,541,828...63,584,122
Ensembl chr18:63,541,896...63,584,119

G

C-C motif chemokine receptor 7

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of CCR7 mRNA

NCBI chr10:84,098,193...84,108,309
Ensembl chr10:84,097,381...84,108,309

G

coiled-coil serine-rich protein 1

increases expression

ethyl-p-hydroxybenzoate results in increased expression of CCSER1 mRNA

NCBI chr 4:90,153,873...91,391,441
Ensembl chr 4:90,292,780...91,388,786

G

CD109 molecule

increases expression

ethyl-p-hydroxybenzoate results in increased expression of CD109 mRNA

NCBI chr 8:79,454,480...79,569,195
Ensembl chr 8:79,454,480...79,569,194

G

CD177 molecule

increases expression

ethyl-p-hydroxybenzoate results in increased expression of CD177 mRNA

NCBI chr 1:80,340,034...80,360,599
Ensembl chr 1:80,340,034...80,360,621

G

CDC42 binding protein kinase gamma

increases expression

ethyl-p-hydroxybenzoate results in increased expression of CDC42BPG mRNA

NCBI chr 1:203,608,339...203,628,502
Ensembl chr 1:203,608,574...203,628,502

G

cadherin 17

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of CDH17 mRNA

NCBI chr 5:25,262,820...25,314,884
Ensembl chr 5:25,262,758...25,314,884

G

cadherin 20

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of CDH20 mRNA

NCBI chr13:20,737,640...21,069,746
Ensembl chr13:20,738,081...21,068,676

G

cadherin-related family member 1

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of CDHR1 mRNA

NCBI chr16:12,843,436...12,863,321
Ensembl chr16:12,843,437...12,863,396

G

cyclin dependent kinase like 1

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of CDKL1 mRNA

NCBI chr 6:88,224,154...88,273,434
Ensembl chr 6:88,224,143...88,270,276

G

cyclin-dependent kinase inhibitor 2A

increases expression

ethyl-p-hydroxybenzoate results in increased expression of CDKN2A mRNA

NCBI chr 5:103,984,949...103,992,143
Ensembl chr 5:103,984,949...104,003,149

G

cyclin dependent kinase inhibitor 2D

increases expression

ethyl-p-hydroxybenzoate results in increased expression of CDKN2D mRNA

NCBI chr 8:19,831,874...19,834,640
Ensembl chr 8:19,831,866...19,834,674

G

CCAAT/enhancer binding protein alpha

increases expression

ethyl-p-hydroxybenzoate results in increased expression of CEBPA mRNA

NCBI chr 1:87,759,631...87,762,303
Ensembl chr 1:87,759,433...87,762,412

G

cell cycle exit and neuronal differentiation 1

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of CEND1 mRNA

NCBI chr 1:196,525,153...196,528,152
Ensembl chr 1:196,523,920...196,528,302

G

cilia and flagella associated protein 107

increases expression

ethyl-p-hydroxybenzoate results in increased expression of CFAP107 mRNA

NCBI chr 5:156,212,385...156,231,481
Ensembl chr 5:156,212,385...156,231,481

G

cilia and flagella associated protein 184

increases expression

ethyl-p-hydroxybenzoate results in increased expression of CFAP184 mRNA

NCBI chr14:74,276,568...74,279,072
Ensembl chr14:74,276,960...74,278,888

G

glycoprotein hormones, alpha polypeptide

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of CGA mRNA

NCBI chr 5:49,486,915...49,499,192
Ensembl chr 5:49,487,068...49,499,191

G

chromodomain helicase DNA binding protein 5

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of CHD5 mRNA

NCBI chr 5:162,848,273...162,898,997
Ensembl chr 5:162,848,394...162,896,291

G

cholinergic receptor nicotinic alpha 4 subunit

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of CHRNA4 mRNA

NCBI chr 3:168,136,246...168,157,839
Ensembl chr 3:168,136,266...168,156,957

G

CBY1 interacting BAR domain containing 2

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of CIBAR2 mRNA

NCBI chr19:48,217,617...48,229,418
Ensembl chr19:48,215,486...48,229,404

G

ciliary microtubule associated protein 3

increases expression

ethyl-p-hydroxybenzoate results in increased expression of CIMAP3 mRNA

NCBI chr 2:193,475,785...193,493,092
Ensembl chr 2:193,475,782...193,493,139

G

claudin 2

increases expression

ethyl-p-hydroxybenzoate results in increased expression of CLDN2 mRNA

NCBI chr X:103,459,870...103,473,794
Ensembl chr X:103,459,780...103,474,838

G

claudin 9

increases expression

ethyl-p-hydroxybenzoate results in increased expression of CLDN9 mRNA

NCBI chr10:12,714,137...12,715,568

G

C-type lectin domain family 18, member A

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of CLEC18A mRNA

NCBI chr19:39,038,498...39,053,425
Ensembl chr19:39,038,273...39,056,017

G

colipase-like 2

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of CLPSL2 mRNA

NCBI chr20:6,608,128...6,610,951
Ensembl chr20:6,608,128...6,610,951

G

clavesin 2

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of CLVS2 mRNA

NCBI chr 1:23,735,660...23,842,685
Ensembl chr 1:23,735,272...23,842,692

G

ciliary neurotrophic factor receptor

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of CNTFR mRNA

NCBI chr 5:56,823,448...56,861,049
Ensembl chr 5:56,823,965...56,841,392

G

contactin associated protein family member 3

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of CNTNAP3 mRNA

NCBI chr17:267,379...455,478
Ensembl chr17:267,508...454,102

G

coronin 6

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of CORO6 mRNA

NCBI chr10:62,311,552...62,319,659
Ensembl chr10:62,311,660...62,319,659

G

cytochrome c oxidase subunit 6B2

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of COX6B2 mRNA

NCBI chr 1:69,094,009...69,095,312

G

copine 7

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of CPNE7 mRNA

NCBI chr19:51,164,316...51,182,676
Ensembl chr19:51,166,034...51,182,677

G

copine family member 9

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of CPNE9 mRNA

NCBI chr 4:146,429,961...146,454,335
Ensembl chr 4:146,430,792...146,454,333

G

crumbs cell polarity complex component 1

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of CRB1 mRNA

NCBI chr13:50,801,484...50,989,261
Ensembl chr13:50,800,959...50,989,261

G

crumbs cell polarity complex component 2

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of CRB2 mRNA

NCBI chr 3:21,542,138...21,564,876
Ensembl chr 3:21,542,221...21,563,294

G

cAMP responsive element binding protein 3-like 3

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of CREB3L3 mRNA

NCBI chr 7:8,622,614...8,631,053
Ensembl chr 7:8,622,614...8,631,048

G

cysteine-rich protein 2

increases expression

ethyl-p-hydroxybenzoate results in increased expression of CRIP2 mRNA

NCBI chr 6:132,221,120...132,226,066
Ensembl chr 6:132,221,082...132,226,065

G

CDP-L-ribitol pyrophosphorylase A

increases expression

ethyl-p-hydroxybenzoate results in increased expression of CRPPA mRNA

NCBI chr 6:53,120,264...53,397,030
Ensembl chr 6:53,121,438...53,397,028

G

crystallin, beta B1

increases expression

ethyl-p-hydroxybenzoate results in increased expression of CRYBB1 mRNA

NCBI chr12:44,369,734...44,383,344
Ensembl chr12:44,369,735...44,383,344

G

crystallin, gamma D

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of CRYGD mRNA

NCBI chr 9:66,442,057...66,443,668
Ensembl chr 9:66,442,054...66,444,067

G

crystallin, mu

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of CRYM mRNA

NCBI chr 1:174,560,423...174,575,660
Ensembl chr 1:174,560,416...174,575,633

G

colony stimulating factor 3 receptor

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of CSF3R mRNA

NCBI chr 5:138,298,605...138,318,224
Ensembl chr 5:138,301,506...138,317,881

G

cytoglobin

increases expression

ethyl-p-hydroxybenzoate results in increased expression of CYGB mRNA

NCBI chr10:101,877,675...101,887,442
Ensembl chr10:101,877,676...101,887,442

G

cytochrome P450, family 19, subfamily a, polypeptide 1

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of CYP19A1 mRNA

NCBI chr 8:54,552,978...54,580,375
Ensembl chr 8:54,553,165...54,580,758

G

cytochrome P450, family 1, subfamily a, polypeptide 1

decreases activity

ethyl-p-hydroxybenzoate results in decreased activity of CYP1A1 protein

NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125

G

cytochrome P450, family 1, subfamily a, polypeptide 2

decreases activity

ethyl-p-hydroxybenzoate results in decreased activity of CYP1A2 protein

NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312

G

cytochrome P450, family 27, subfamily a, polypeptide 1

increases expression

ethyl-p-hydroxybenzoate results in increased expression of CYP27A1 mRNA

NCBI chr 9:76,264,655...76,294,551
Ensembl chr 9:76,264,860...76,294,551

G

cytochrome P450, family 2, subfamily b, polypeptide 1

decreases activity

ethyl-p-hydroxybenzoate results in decreased activity of CYP2B1 protein

NCBI chr 1:81,518,387...81,544,999
Ensembl chr 1:81,518,408...81,542,052

G

cytochrome P450, subfamily 2, polypeptide 11

decreases activity

ethyl-p-hydroxybenzoate results in decreased activity of CYP2C11 protein

NCBI chr 1:236,762,719...236,799,069
Ensembl chr 1:236,762,842...236,799,066

G

cytochrome P450, family 2, subfamily e, polypeptide 1

decreases activity

ethyl-p-hydroxybenzoate results in decreased activity of CYP2E1 protein

NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023

G

cytochrome P450, family 3, subfamily a, polypeptide 62

decreases activity

ethyl-p-hydroxybenzoate results in decreased activity of CYP3A62 protein

NCBI chr12:16,397,998...16,433,833
Ensembl chr12:16,397,998...16,433,833

G

cytochrome P450, family 4, subfamily f, polypeptide 39

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of CYP4F22 mRNA

NCBI chr 7:11,426,806...11,505,553
Ensembl chr 7:11,433,371...11,536,181

G

cytochrome P450 family 7 subfamily B member 1

increases expression

ethyl-p-hydroxybenzoate results in increased expression of CYP7B1 mRNA

NCBI chr 2:100,502,791...100,669,713
Ensembl chr 2:100,502,791...100,669,698

G

doublecortin-like kinase 2

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of DCLK2 mRNA

NCBI chr 2:172,202,733...172,338,411
Ensembl chr 2:172,208,706...172,338,250

G

doublecortin-like kinase 3

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of DCLK3 mRNA

NCBI chr 8:111,401,544...111,453,999
Ensembl chr 8:111,401,358...111,453,999

G

DEF6 guanine nucleotide exchange factor

increases expression

ethyl-p-hydroxybenzoate results in increased expression of DEF6 mRNA

NCBI chr20:6,268,579...6,290,030
Ensembl chr20:6,268,601...6,289,961

G

diacylglycerol kinase, iota

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of DGKI mRNA

NCBI chr 4:65,410,878...65,872,733
Ensembl chr 4:65,420,108...65,872,733

G

dickkopf WNT signaling pathway inhibitor 2

increases expression

ethyl-p-hydroxybenzoate results in increased expression of DKK2 mRNA

NCBI chr 2:220,568,338...220,660,225
Ensembl chr 2:220,568,338...220,660,225

G

dickkopf WNT signaling pathway inhibitor 4

increases expression

ethyl-p-hydroxybenzoate results in increased expression of DKK4 mRNA

NCBI chr16:69,403,215...69,406,580
Ensembl chr16:69,402,989...69,406,580

G

dickkopf like acrosomal protein 1

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of DKKL1 mRNA

NCBI chr 1:95,694,010...95,699,259
Ensembl chr 1:95,694,010...95,699,259

G

DLEC1 cilia and flagella associated protein

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of DLEC1 mRNA

NCBI chr 8:118,826,429...118,873,183
Ensembl chr 8:118,826,466...118,873,655

G

deleted in lymphocytic leukemia, 7

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of DLEU7 mRNA

NCBI chr15:36,479,533...36,495,730
Ensembl chr15:36,479,534...36,495,697

G

diencephalon/mesencephalon homeobox 1

increases expression

ethyl-p-hydroxybenzoate results in increased expression of DMBX1 mRNA

NCBI chr 5:129,394,221...129,403,040
Ensembl chr 5:129,394,221...129,403,040

G

DMRT-like family A2

increases expression

ethyl-p-hydroxybenzoate results in increased expression of DMRTA2 mRNA

NCBI chr 5:124,805,883...124,811,694
Ensembl chr 5:124,805,883...124,811,630

G

dynein axonemal intermediate chain 3

increases expression

ethyl-p-hydroxybenzoate results in increased expression of DNAI3 mRNA

NCBI chr 2:234,947,910...235,006,173
Ensembl chr 2:234,929,677...235,006,173

G

dynamin 1

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of DNM1 mRNA

NCBI chr 3:15,604,782...15,648,654
Ensembl chr 3:15,604,784...15,648,538

G

dynamin 3

increases expression

ethyl-p-hydroxybenzoate results in increased expression of DNM3 mRNA

NCBI chr13:74,359,043...74,838,135
Ensembl chr13:74,359,213...74,838,108

G

DNA methyltransferase 3 like

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of DNMT3L mRNA

NCBI chr20:10,614,933...10,629,337
Ensembl chr20:10,614,934...10,629,516

G

double C2 domain alpha

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of DOC2A mRNA

NCBI chr 1:181,457,415...181,462,528
Ensembl chr 1:181,458,390...181,462,030

G

docking protein 3

increases expression

ethyl-p-hydroxybenzoate results in increased expression of DOK3 mRNA

NCBI chr17:9,109,633...9,115,188
Ensembl chr17:9,109,597...9,115,188

G

developmental pluripotency-associated 3

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of DPPA3 mRNA

NCBI chr 4:155,851,461...155,854,845
Ensembl chr 4:155,815,296...155,854,861
Ensembl chr 5:155,815,296...155,854,861

G

desmocollin 1

increases expression

ethyl-p-hydroxybenzoate results in increased expression of DSC1 mRNA

NCBI chr18:11,499,936...11,556,801
Ensembl chr18:11,502,003...11,528,494

G

desmoglein 3

increases expression

ethyl-p-hydroxybenzoate results in increased expression of DSG3 mRNA

NCBI chr18:11,799,355...11,830,988
Ensembl chr18:11,798,900...11,830,818

G

deltex E3 ubiquitin ligase 1

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of DTX1 mRNA

NCBI chr12:35,849,647...35,880,835
Ensembl chr12:35,849,617...35,880,838

G

dual specificity phosphatase 10

increases expression

ethyl-p-hydroxybenzoate results in increased expression of DUSP10 mRNA

NCBI chr13:95,613,716...95,651,716
Ensembl chr13:95,614,292...95,651,716

G

dual specificity phosphatase 9

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of DUSP9 mRNA

NCBI chr X:151,351,897...151,355,822
Ensembl chr X:151,351,897...151,355,821

G

DPY30 domain containing 2

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of DYDC2 mRNA

NCBI chr16:16,928,172...16,941,950
Ensembl chr16:16,928,194...16,936,164

G

dual specificity tyrosine phosphorylation regulated kinase 3

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of DYRK3 mRNA

NCBI chr13:42,594,120...42,604,898
Ensembl chr13:42,594,121...42,604,778

G

dysferlin

increases expression

ethyl-p-hydroxybenzoate results in increased expression of DYSF mRNA

NCBI chr 4:116,490,877...116,690,709
Ensembl chr 4:116,490,616...116,690,709

G

DAZ interacting zinc finger protein 1-like

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of DZIP1L mRNA

NCBI chr 8:100,188,414...100,229,077
Ensembl chr 8:100,194,999...100,228,988

G

Epstein-Barr virus induced 3

increases expression

ethyl-p-hydroxybenzoate results in increased expression of EBI3 mRNA

NCBI chr 9:774,252...787,544
Ensembl chr 9:783,617...787,544

G

EGF-like, fibronectin type III and laminin G domains

increases expression

ethyl-p-hydroxybenzoate results in increased expression of EGFLAM mRNA

NCBI chr 2:56,301,945...56,476,665
Ensembl chr 2:56,302,566...56,476,298

G

elastin

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of ELN mRNA

NCBI chr12:21,968,544...22,011,929
Ensembl chr12:21,968,544...22,011,928

G

elastin microfibril interfacer 3

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of EMILIN3 mRNA

NCBI chr 3:149,558,785...149,564,785
Ensembl chr 3:149,558,970...149,564,785

G

EPH receptor A10

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of EPHA10 mRNA

NCBI chr 5:137,139,588...137,175,637
Ensembl chr 5:137,140,735...137,174,157

G

Eph receptor A8

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of EPHA8 mRNA

NCBI chr 5:149,166,107...149,193,515
Ensembl chr 5:149,166,697...149,193,399

G

epoxide hydrolase 1

increases expression

ethyl-p-hydroxybenzoate results in increased expression of EPHX1 mRNA

NCBI chr13:92,714,315...92,744,105
Ensembl chr13:92,714,315...92,790,235

G

erythroferrone

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of ERFE mRNA

NCBI chr 9:91,956,971...91,964,846
Ensembl chr 9:91,956,977...91,964,846

G

endogenous retrovirus group FRD member 1, envelope

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of ERVFRD-1 mRNA

NCBI chr12:22,151,211...22,158,264
Ensembl chr12:22,151,211...22,158,264

G

endogenous retrovirus group V member 2, envelope

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of ERVV-2 mRNA

NCBI chr 3:119,129,119...119,135,004
Ensembl chr 3:119,131,071...119,131,670

G

endothelial cell adhesion molecule

increases expression

ethyl-p-hydroxybenzoate results in increased expression of ESAM mRNA

NCBI chr 8:37,238,228...37,249,217
Ensembl chr 8:37,238,287...37,249,215

G

estrogen receptor 1

multiple interactions
increases activity
affects binding

ethyl-p-hydroxybenzoate binds to and results in increased activity of ESR1 protein
ethyl-p-hydroxybenzoate results in increased activity of ESR1 protein
ethyl-p-hydroxybenzoate binds to ESR1 protein

PMID:11193391 PMID:20132880 PMID:23567241 PMID:25012808 PMID:29162470

NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002

G

estrogen receptor 2

affects binding
multiple interactions

ethyl-p-hydroxybenzoate binds to ESR2 protein
ethyl-p-hydroxybenzoate binds to and results in increased activity of ESR2 protein

PMID:11193391 PMID:20132880 PMID:23567241

NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919

G

epithelial splicing regulatory protein 2

increases expression

ethyl-p-hydroxybenzoate results in increased expression of ESRP2 mRNA

NCBI chr19:34,034,559...34,041,726
Ensembl chr19:34,034,559...34,041,726

G

estrogen-related receptor beta

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of ESRRB mRNA

NCBI chr 6:106,007,701...106,163,136
Ensembl chr 6:106,008,095...106,160,791

G

estrogen-related receptor gamma

multiple interactions

ethyl-p-hydroxybenzoate inhibits the reaction [afimoxifene inhibits the reaction [ESRRG protein binds to NCOA2 protein]]

NCBI chr13:99,167,656...99,788,016
Ensembl chr13:99,564,669...99,783,397

G

eva-1 homolog B

increases expression

ethyl-p-hydroxybenzoate results in increased expression of EVA1B mRNA

NCBI chr 5:138,427,088...138,429,602
Ensembl chr 5:138,427,151...138,432,433

G

coagulation factor X

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of F10 mRNA

NCBI chr16:76,468,834...76,488,141
Ensembl chr16:76,468,838...76,488,141

G

coagulation factor VII

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of F7 mRNA

NCBI chr16:76,489,775...76,500,636
Ensembl chr16:76,489,717...76,500,610

G

fatty acid binding protein 3

increases expression

ethyl-p-hydroxybenzoate results in increased expression of FABP3 mRNA

NCBI chr 5:142,651,962...142,658,707
Ensembl chr 5:142,651,956...142,658,718

G

fatty acid binding protein 4

increases expression

ethyl-p-hydroxybenzoate results in increased expression of FABP4 mRNA

NCBI chr 2:91,580,879...91,585,567
Ensembl chr 2:91,580,885...91,585,578

G

Fas apoptotic inhibitory molecule 2

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of FAIM2 mRNA

NCBI chr 7:130,632,368...130,659,353
Ensembl chr 7:130,633,348...130,659,168

G

family with sequence similarity 131, member C

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of FAM131C mRNA

NCBI chr 5:153,674,459...153,690,791
Ensembl chr 5:153,671,772...153,690,800

G

family with sequence similarity 163, member B

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of FAM163B mRNA

NCBI chr 3:10,437,383...10,466,458
Ensembl chr 3:10,437,383...10,466,458

G

family with sequence similarity 219, member A

increases expression

ethyl-p-hydroxybenzoate results in increased expression of FAM219A mRNA

NCBI chr 5:56,679,272...56,729,959
Ensembl chr 5:56,680,613...56,729,924

G

family with sequence similarity 228, member A

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of FAM228A mRNA

NCBI chr 6:27,727,982...27,750,140
Ensembl chr 6:27,727,984...27,750,061

G

F-box protein 43

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of FBXO43 mRNA

NCBI chr 7:67,333,161...67,346,751
Ensembl chr 7:67,333,162...67,346,751

G

F-box and WD repeat domain containing 12

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of FBXW12 mRNA

NCBI chr 8:109,782,315...109,802,086
Ensembl chr 8:109,786,815...109,801,813

G

Fc gamma binding protein

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of FCGBP mRNA

NCBI chr 1:83,374,979...83,413,082
Ensembl chr 1:83,372,127...83,413,083

G

fer-1-like family member 5

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of FER1L5 mRNA

NCBI chr 9:38,605,835...38,661,869
Ensembl chr 9:38,607,843...38,660,425

G

Fez family zinc finger 1

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of FEZF1 mRNA

NCBI chr 4:51,762,751...51,766,078
Ensembl chr 4:51,762,751...51,766,078

G

Fez family zinc finger 2

increases expression

ethyl-p-hydroxybenzoate results in increased expression of FEZF2 mRNA

NCBI chr15:12,768,614...12,777,554
Ensembl chr15:12,773,762...12,777,554

G

FYVE, RhoGEF and PH domain containing 5

increases expression

ethyl-p-hydroxybenzoate results in increased expression of FGD5 mRNA

NCBI chr 4:124,497,061...124,594,564
Ensembl chr 4:124,497,068...124,594,563

G

fibroblast growth factor 1

increases expression

ethyl-p-hydroxybenzoate results in increased expression of FGF1 mRNA

NCBI chr18:30,686,555...30,772,667
Ensembl chr18:30,686,581...30,772,357

G

fibroblast growth factor 10

increases expression

ethyl-p-hydroxybenzoate results in increased expression of FGF10 mRNA

NCBI chr 2:50,801,171...50,878,218
Ensembl chr 2:50,800,992...50,876,866

G

fibroblast growth factor 23

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of FGF23 mRNA

NCBI chr 4:159,914,267...159,923,821
Ensembl chr 4:159,914,272...159,923,821

G

fibroblast growth factor 4

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of FGF4 mRNA

NCBI chr 1:200,023,937...200,027,793
Ensembl chr 1:200,024,056...200,025,466

G

fibroblast growth factor 9

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of FGF9 mRNA

NCBI chr15:32,208,993...32,254,952
Ensembl chr15:32,210,074...32,253,309

G

fibroblast growth factor binding protein 1

increases expression

ethyl-p-hydroxybenzoate results in increased expression of FGFBP1 mRNA

NCBI chr14:67,103,686...67,107,492
Ensembl chr14:67,104,545...67,107,496

G

FGGY carbohydrate kinase domain containing

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of FGGY mRNA

NCBI chr 5:110,398,866...110,786,019
Ensembl chr 5:110,398,863...110,786,017

G

fibrinogen C domain containing 1

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of FIBCD1 mRNA

NCBI chr 3:15,092,682...15,126,371
Ensembl chr 3:15,092,681...15,126,399

G

fin bud initiation factor homolog

increases expression

ethyl-p-hydroxybenzoate results in increased expression of FIBIN mRNA

NCBI chr 3:96,942,405...96,944,676
Ensembl chr 3:96,942,406...96,944,676

G

filamin B

increases expression

ethyl-p-hydroxybenzoate results in increased expression of FLNB mRNA

NCBI chr15:16,961,999...17,095,059
Ensembl chr15:16,962,003...17,095,006

G

filamin C

increases expression

ethyl-p-hydroxybenzoate results in increased expression of FLNC mRNA

NCBI chr 4:58,034,088...58,061,882
Ensembl chr 4:58,034,189...58,061,844

G

Fms related receptor tyrosine kinase 3

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of FLT3 mRNA

NCBI chr12:7,623,930...7,699,474
Ensembl chr12:7,623,930...7,699,474

G

flavin containing dimethylaniline monoxygenase 4

increases expression

ethyl-p-hydroxybenzoate results in increased expression of FMO4 mRNA

NCBI chr13:75,154,683...75,172,874
Ensembl chr13:75,154,684...75,172,874

G

fibromodulin

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of FMOD mRNA

NCBI chr13:45,493,517...45,504,134
Ensembl chr13:45,493,517...45,504,133

G

fibronectin type III domain containing 10

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of FNDC10 mRNA

NCBI chr 5:166,299,587...166,311,477
Ensembl chr 5:166,300,122...166,310,326

G

forkhead box D3

increases expression

ethyl-p-hydroxybenzoate results in increased expression of FOXD3 mRNA

NCBI chr 5:114,335,084...114,337,450
Ensembl chr 5:114,335,408...114,336,817

G

forkhead box I2

increases expression

ethyl-p-hydroxybenzoate results in increased expression of FOXI2 mRNA

NCBI chr 1:190,222,857...190,226,657
Ensembl chr 1:190,222,703...190,226,433

G

forkhead box I3

increases expression

ethyl-p-hydroxybenzoate results in increased expression of FOXI3 mRNA

NCBI chr 4:102,933,487...102,937,655
Ensembl chr 4:102,933,409...102,937,655

G

forkhead box N4

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of FOXN4 mRNA

NCBI chr12:42,336,706...42,359,932
Ensembl chr12:42,340,323...42,359,921

G

FERM domain containing 1

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of FRMD1 mRNA

NCBI chr 1:55,079,285...55,090,230

G

FERM domain containing 6

increases expression

ethyl-p-hydroxybenzoate results in increased expression of FRMD6 mRNA

NCBI chr 6:89,345,983...89,419,579
Ensembl chr 6:89,346,035...89,419,579

G

FERM and PDZ domain containing 3

increases expression

ethyl-p-hydroxybenzoate results in increased expression of FRMPD3 mRNA

NCBI chr X:103,964,168...104,113,864
Ensembl chr X:104,043,194...104,111,968

G

ferric-chelate reductase 1

increases expression

ethyl-p-hydroxybenzoate results in increased expression of FRRS1 mRNA

NCBI chr 2:204,820,898...204,881,487
Ensembl chr 2:204,823,025...204,895,540

G

FXYD domain-containing ion transport regulator 1

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of FXYD1 mRNA

NCBI chr 1:86,287,163...86,291,478
Ensembl chr 1:86,287,165...86,291,278

G

FXYD domain-containing ion transport regulator 2

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of FXYD2 mRNA

NCBI chr 8:45,712,901...45,720,032
Ensembl chr 8:45,712,903...45,720,203

G

FXYD domain-containing ion transport regulator 7

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of FXYD7 mRNA

NCBI chr 1:86,277,678...86,286,954
Ensembl chr 1:86,277,678...86,286,954

G

gamma-aminobutyric acid type A receptor subunit alpha 3

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of GABRA3 mRNA

NCBI chr X:150,244,745...150,501,566
Ensembl chr X:150,261,607...150,501,559

G

glutamate decarboxylase 2

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of GAD2 mRNA

NCBI chr17:84,763,630...84,826,155
Ensembl chr17:84,763,628...84,826,155

G

growth arrest and DNA-damage-inducible, alpha

increases expression

ethyl-p-hydroxybenzoate results in increased expression of GADD45A mRNA

NCBI chr 4:96,154,789...96,157,091
Ensembl chr 4:96,154,789...96,157,115

G

galanin receptor 1

increases expression

ethyl-p-hydroxybenzoate results in increased expression of GALR1 mRNA

NCBI chr18:75,772,021...75,787,577
Ensembl chr18:75,772,023...75,787,577

G

golgi associated RAB2 interactor family member 5B

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of GARIN5B mRNA

NCBI chr 1:69,076,839...69,093,877
Ensembl chr 1:69,077,207...69,095,316

G

GTPase activating Rap/RanGAP domain-like 3

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of GARNL3 mRNA

NCBI chr 3:16,288,718...16,432,308
Ensembl chr 3:16,288,719...16,430,837

G

growth arrest-specific 2 like 2

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of GAS2L2 mRNA

NCBI chr10:68,222,475...68,229,877
Ensembl chr10:68,222,475...68,229,881

G

1,4-alpha-glucan branching enzyme 1

increases expression

ethyl-p-hydroxybenzoate results in increased expression of GBE1 mRNA

NCBI chr11:8,734,806...9,000,226
Ensembl chr11:8,734,820...9,000,210

G

guanylate binding protein 4

increases expression

ethyl-p-hydroxybenzoate results in increased expression of GBP4 mRNA

NCBI chr 2:231,304,910...231,318,883
Ensembl chr 2:231,305,244...231,318,879

G

glucokinase regulator

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of GCKR mRNA

NCBI chr 6:25,044,592...25,075,834
Ensembl chr 6:25,045,100...25,075,654

G

glial cells missing transcription factor 1

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of GCM1 mRNA

NCBI chr 8:78,925,687...78,938,924
Ensembl chr 8:78,925,687...78,938,924

G

glucosaminyl (N-acetyl) transferase 4

increases expression

ethyl-p-hydroxybenzoate results in increased expression of GCNT4 mRNA

NCBI chr 2:28,253,325...28,283,082
Ensembl chr 2:28,252,860...28,283,082

G

ganglioside-induced differentiation-associated protein 1-like 1

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of GDAP1L1 mRNA

NCBI chr 3:152,110,225...152,129,693
Ensembl chr 3:152,110,253...152,128,711

G

growth differentiation factor 5

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of GDF5 mRNA

NCBI chr 3:144,454,316...144,458,508
Ensembl chr 3:144,454,338...144,458,612

G

growth differentiation factor 6

increases expression

ethyl-p-hydroxybenzoate results in increased expression of GDF6 mRNA

NCBI chr 5:22,996,246...23,012,567
Ensembl chr 5:22,996,246...23,012,567

G

glial cell derived neurotrophic factor

increases expression

ethyl-p-hydroxybenzoate results in increased expression of GDNF mRNA

NCBI chr 2:56,894,022...56,919,935
Ensembl chr 2:56,895,010...56,917,209

G

GDNF family receptor alpha 2

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of GFRA2 mRNA

NCBI chr15:45,941,841...46,033,715
Ensembl chr15:45,941,828...46,033,714

G

golgi-associated, olfactory signaling regulator

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of GFY mRNA

NCBI chr 1:95,661,621...95,665,300
Ensembl chr 1:95,661,773...95,665,893

G

GIPC PDZ domain containing family, member 3

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of GIPC3 mRNA

NCBI chr 7:8,374,941...8,383,281

G

gap junction protein, beta 2

increases expression

ethyl-p-hydroxybenzoate results in increased expression of GJB2 mRNA

NCBI chr15:31,260,390...31,278,222
Ensembl chr15:31,260,357...31,278,177

G

gap junction protein, beta 3

increases expression

ethyl-p-hydroxybenzoate results in increased expression of GJB3 mRNA

NCBI chr 5:139,649,227...139,654,970
Ensembl chr 5:139,649,195...139,654,980

G

gap junction protein, gamma 2

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of GJC2 mRNA

NCBI chr10:43,962,642...43,971,358
Ensembl chr10:43,962,642...43,970,467

G

gliomedin

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of GLDN mRNA

NCBI chr 8:54,679,015...54,723,198
Ensembl chr 8:54,679,119...54,723,196

G

GLI family zinc finger 1

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of GLI1 mRNA

NCBI chr 7:63,156,926...63,169,579
Ensembl chr 7:63,156,926...63,169,251

G

glucagon-like peptide 1 receptor

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of GLP1R mRNA

NCBI chr20:8,972,004...9,010,241
Ensembl chr20:8,972,004...9,010,241

G

G protein subunit alpha 14

increases expression

ethyl-p-hydroxybenzoate results in increased expression of GNA14 mRNA

NCBI chr 1:213,714,993...213,900,083
Ensembl chr 1:213,716,020...213,897,423

G

gonadotropin releasing hormone receptor

increases expression

ethyl-p-hydroxybenzoate results in increased expression of GNRHR mRNA

NCBI chr14:21,856,871...21,874,861
Ensembl chr14:21,856,871...21,874,861

G

glycerol-3-phosphate acyltransferase 3

increases expression

ethyl-p-hydroxybenzoate results in increased expression of GPAT3 mRNA

NCBI chr14:8,715,367...8,768,051
Ensembl chr14:8,714,373...8,766,490

G

glypican 5

increases expression

ethyl-p-hydroxybenzoate results in increased expression of GPC5 mRNA

NCBI chr15:92,207,275...93,644,054
Ensembl chr15:92,239,176...93,643,282

G

G protein-coupled receptor 142

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of GPR142 mRNA

NCBI chr10:99,840,069...99,843,410
Ensembl chr10:99,840,069...99,843,410

G

G protein-coupled receptor 153

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of GPR153 mRNA

NCBI chr 5:162,781,587...162,792,975
Ensembl chr 5:162,781,587...162,792,971

G

G protein-coupled receptor 39

increases expression

ethyl-p-hydroxybenzoate results in increased expression of GPR39 mRNA

NCBI chr13:37,115,258...37,327,312
Ensembl chr13:37,115,102...37,328,267

G

G protein-coupled receptor 61

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of GPR61 mRNA

NCBI chr 2:195,781,931...195,789,798
Ensembl chr 2:195,782,752...195,789,621

G

GRB2-related adaptor protein

increases expression

ethyl-p-hydroxybenzoate results in increased expression of GRAP mRNA

NCBI chr10:46,298,965...46,352,057
Ensembl chr10:46,332,909...46,352,056

G

growth regulating estrogen receptor binding 1

increases expression

ethyl-p-hydroxybenzoate results in increased expression of GREB1 mRNA

NCBI chr 6:39,440,522...39,562,364
Ensembl chr 6:39,440,504...39,581,633

G

glutamate ionotropic receptor kainate type subunit 2

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of GRIK2 mRNA

NCBI chr20:52,135,325...52,833,061
Ensembl chr20:52,133,851...52,838,375

G

glutamate ionotropic receptor kainate type subunit 3

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of GRIK3 mRNA

NCBI chr 5:137,767,865...137,989,617
Ensembl chr 5:137,767,865...137,984,307

G

glutamate ionotropic receptor NMDA type subunit 2A

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of GRIN2A mRNA

NCBI chr10:5,629,683...6,053,262
Ensembl chr10:5,631,369...6,044,637

G

glutamate metabotropic receptor 2

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of GRM2 mRNA

NCBI chr 8:107,280,099...107,293,159
Ensembl chr 8:107,280,099...107,293,146

G

glutathione S-transferase, mu 5-like

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of GSTM5 mRNA

NCBI chr 2:195,544,424...195,549,895
Ensembl chr 2:195,544,426...195,628,961

G

guanylate cyclase activator 1A

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of GUCA1A mRNA

NCBI chr 9:13,588,988...13,598,566
Ensembl chr 9:13,588,525...13,598,565

G

H2A.J histone

increases expression

ethyl-p-hydroxybenzoate results in increased expression of H2AJ mRNA

NCBI chr 4:169,675,718...169,676,202
Ensembl chr 4:169,675,752...169,677,006

G

huntingtin-associated protein 1

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of HAP1 mRNA

NCBI chr10:85,277,890...85,286,126
Ensembl chr10:85,277,890...85,286,126

G

hepatitis A virus cellular receptor 1

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of HAVCR1 mRNA

NCBI chr10:31,118,667...31,151,730
Ensembl chr10:31,119,088...31,151,698

G

HCK proto-oncogene, Src family tyrosine kinase

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of HCK mRNA

NCBI chr 3:141,571,587...141,614,696
Ensembl chr 3:141,571,587...141,614,693

G

hematopoietic cell specific Lyn substrate 1

increases expression

ethyl-p-hydroxybenzoate results in increased expression of HCLS1 mRNA

NCBI chr11:63,817,482...63,840,943
Ensembl chr11:63,817,476...63,841,014

G

HECT, C2 and WW domain containing E3 ubiquitin protein ligase 1

increases expression

ethyl-p-hydroxybenzoate results in increased expression of HECW1 mRNA

NCBI chr17:50,671,239...51,084,536
Ensembl chr17:50,670,954...51,080,720

G

hes family bHLH transcription factor 3

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of HES3 mRNA

NCBI chr 5:162,793,611...162,799,578
Ensembl chr 5:162,794,367...162,796,261

G

hes-related family bHLH transcription factor with YRPW motif-like

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of HEYL mRNA

NCBI chr 5:135,508,160...135,525,152
Ensembl chr 5:135,508,160...135,525,152

G

HHIP like 2

increases expression

ethyl-p-hydroxybenzoate results in increased expression of HHIPL2 mRNA

NCBI chr13:95,054,685...95,074,609
Ensembl chr13:95,054,694...95,074,608

G

histone cluster 2 H3 family member C2

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of H3C14 mRNA

NCBI chr 2:183,837,296...183,837,721
Ensembl chr 2:183,837,303...183,837,752

G

HOATZ cilia and flagella associated protein

increases expression

ethyl-p-hydroxybenzoate results in increased expression of HOATZ mRNA

NCBI chr 8:51,385,931...51,409,796
Ensembl chr 8:51,388,382...51,412,514

G

homeobox A10

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of HOXA10 protein

NCBI chr 4:81,331,591...81,340,878
Ensembl chr 4:81,331,591...81,340,919

G

hippocalcin

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of HPCA mRNA

NCBI chr 5:141,455,616...141,466,252
Ensembl chr 5:141,455,613...141,463,841

G

hippocalcin-like 4

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of HPCAL4 mRNA

NCBI chr 5:135,454,477...135,466,417
Ensembl chr 5:135,454,540...135,466,416

G

histidine rich calcium binding protein

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of HRC mRNA

NCBI chr 1:95,813,262...95,816,987
Ensembl chr 1:95,813,253...95,816,984

G

histamine receptor H3

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of HRH3 mRNA

NCBI chr 3:167,191,551...167,196,642
Ensembl chr 3:167,191,558...167,196,642

G

heparan sulfate-glucosamine 3-sulfotransferase 2

increases expression

ethyl-p-hydroxybenzoate results in increased expression of HS3ST2 mRNA

NCBI chr 1:175,956,161...176,077,400
Ensembl chr 1:175,956,157...176,077,399

G

hydroxysteroid 11-beta dehydrogenase 2

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of HSD11B2 mRNA

NCBI chr19:33,397,656...33,402,899
Ensembl chr19:33,397,656...33,402,899

G

hydroxysteroid (17-beta) dehydrogenase 1

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of HSD17B1 mRNA

NCBI chr10:86,009,728...86,011,928
Ensembl chr10:86,009,728...86,011,927

G

hematopoietic SH2 domain containing

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of HSH2D mRNA

NCBI chr16:17,630,519...17,649,932
Ensembl chr16:17,635,322...17,647,991

G

heat shock protein family A (Hsp70) member 12B

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of HSPA12B mRNA

NCBI chr 3:118,346,372...118,364,374
Ensembl chr 3:118,346,354...118,364,737

G

5-hydroxytryptamine receptor 1D

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of HTR1D mRNA

NCBI chr 5:148,656,252...148,676,532
Ensembl chr 5:148,674,495...148,675,619

G

5-hydroxytryptamine receptor 6

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of HTR6 mRNA

NCBI chr 5:151,295,269...151,312,853
Ensembl chr 5:151,296,662...151,311,912

G

intercellular adhesion molecule 5

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of ICAM5 mRNA

NCBI chr 8:19,567,390...19,575,588
Ensembl chr 8:19,568,600...19,575,588

G

interferon, alpha-inducible protein 27 like 2A

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of IFI27L2 mRNA

NCBI chr 6:122,598,872...122,600,358
Ensembl chr 6:122,598,872...122,600,360

G

insulin-like growth factor 2

increases expression

ethyl-p-hydroxybenzoate results in increased expression of IGF2 mRNA

NCBI chr 1:197,814,409...197,831,802
Ensembl chr 1:197,814,410...197,823,018

G

interleukin 17 receptor E

increases expression

ethyl-p-hydroxybenzoate results in increased expression of IL17RE mRNA

NCBI chr 4:146,604,547...146,618,206
Ensembl chr 4:146,605,526...146,618,206

G

interleukin 36 receptor antagonist

increases expression

ethyl-p-hydroxybenzoate results in increased expression of IL36RN mRNA

NCBI chr 3:7,044,419...7,051,016
Ensembl chr 3:7,044,406...7,051,016

G

inositol hexakisphosphate kinase 3

increases expression

ethyl-p-hydroxybenzoate results in increased expression of IP6K3 mRNA

NCBI chr20:5,223,863...5,245,443
Ensembl chr20:5,224,120...5,245,428

G

IQ motif and ankyrin repeat containing 1

increases expression

ethyl-p-hydroxybenzoate results in increased expression of IQANK1 mRNA

NCBI chr 7:107,724,962...107,759,163
Ensembl chr 7:107,724,997...107,759,162

G

IQ motif and Sec7 domain ArfGEF 3

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of IQSEC3 mRNA

NCBI chr 4:154,610,933...154,707,310
Ensembl chr 4:154,610,934...154,707,310

G

interferon regulatory factor 4

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of IRF4 mRNA

NCBI chr17:33,721,800...33,742,570
Ensembl chr17:33,721,811...33,740,070

G

iroquois homeobox 1

increases expression

ethyl-p-hydroxybenzoate results in increased expression of IRX1 mRNA

NCBI chr 1:31,294,615...31,300,444
Ensembl chr 1:31,294,615...31,300,444

G

integrin subunit alpha 3

increases expression

ethyl-p-hydroxybenzoate results in increased expression of ITGA3 mRNA

NCBI chr10:79,990,160...80,022,206
Ensembl chr10:79,990,161...80,022,118

G

integrin subunit beta 4

increases expression

ethyl-p-hydroxybenzoate results in increased expression of ITGB4 mRNA

NCBI chr10:101,206,657...101,243,012
Ensembl chr10:101,206,665...101,243,012

G

Janus kinase 1

increases expression

ethyl-p-hydroxybenzoate results in increased expression of JAK1 mRNA

NCBI chr 5:115,780,248...115,888,841
Ensembl chr 5:115,780,248...115,888,926

G

janus kinase and microtubule interacting protein 1

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of JAKMIP1 mRNA

NCBI chr14:73,646,299...73,766,830
Ensembl chr14:73,632,428...73,713,993

G

junctional adhesion molecule 2

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of JAM2 mRNA

NCBI chr11:23,830,820...23,880,071
Ensembl chr11:23,831,106...23,880,063

G

junctophilin 4

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of JPH4 mRNA

NCBI chr15:28,579,579...28,588,903
Ensembl chr15:28,571,568...28,587,573

G

KASH domain containing 5

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of KASH5 mRNA

NCBI chr 1:95,668,918...95,691,353
Ensembl chr 1:95,668,886...95,691,368

G

potassium voltage-gated channel subfamily A regulatory beta subunit 3

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of KCNAB3 mRNA

NCBI chr10:54,047,830...54,056,401
Ensembl chr10:54,047,825...54,054,174

G

potassium voltage-gated channel subfamily C member 1

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of KCNC1 mRNA

NCBI chr 1:96,902,953...96,944,744
Ensembl chr 1:96,902,953...96,944,744

G

potassium voltage-gated channel modifier subfamily F member 1

increases expression

ethyl-p-hydroxybenzoate results in increased expression of KCNF1 mRNA

NCBI chr 6:39,962,301...39,964,979
Ensembl chr 6:39,962,307...39,964,979

G

potassium voltage-gated channel subfamily H member 1

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of KCNH1 mRNA

NCBI chr13:103,722,140...104,024,762
Ensembl chr13:103,722,245...104,024,740

G

potassium voltage-gated channel subfamily H member 6

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of KCNH6 mRNA

NCBI chr10:90,949,240...90,970,746
Ensembl chr10:90,949,846...90,970,701

G

potassium voltage-gated channel interacting protein 1

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of KCNIP1 mRNA

NCBI chr10:18,219,519...18,588,833
Ensembl chr10:18,219,519...18,589,045

G

potassium voltage-gated channel interacting protein 4

increases expression

ethyl-p-hydroxybenzoate results in increased expression of KCNIP4 mRNA

NCBI chr14:61,380,699...62,531,399
Ensembl chr14:61,381,076...62,530,144

G

potassium inwardly-rectifying channel, subfamily J, member 11

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of KCNJ11 mRNA

NCBI chr 1:96,591,048...96,594,574
Ensembl chr 1:96,591,049...96,594,082

G

potassium two pore domain channel subfamily K member 9

increases expression

ethyl-p-hydroxybenzoate results in increased expression of KCNK9 mRNA

NCBI chr 7:104,429,186...104,473,924
Ensembl chr 7:104,437,934...104,473,175

G

potassium voltage-gated channel subfamily Q member 3

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of KCNQ3 mRNA

NCBI chr 7:97,730,219...98,025,652
Ensembl chr 7:97,730,465...98,025,653

G

KIAA1614 homolog

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of KIAA1614 mRNA

NCBI chr13:67,388,916...67,427,392
Ensembl chr13:67,389,044...67,421,272

G

kinesin family member 17

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of KIF17 mRNA

NCBI chr 5:150,482,288...150,521,471
Ensembl chr 5:150,481,578...150,519,638

G

kinesin family member C3

increases expression

ethyl-p-hydroxybenzoate results in increased expression of KIFC3 mRNA

NCBI chr19:9,825,114...9,920,371
Ensembl chr19:9,886,693...9,920,451

G

kinase non-catalytic C-lobe domain containing 1

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of KNDC1 mRNA

NCBI chr 1:194,689,962...194,738,353
Ensembl chr 1:194,690,135...194,738,362

G

keratin 15

increases expression

ethyl-p-hydroxybenzoate results in increased expression of KRT15 mRNA

NCBI chr10:85,066,797...85,070,614
Ensembl chr10:85,066,802...85,171,799

G

keratin 80

increases expression

ethyl-p-hydroxybenzoate results in increased expression of KRT80 mRNA

NCBI chr 7:132,463,216...132,485,134
Ensembl chr 7:132,463,218...132,485,508

G

L3MBTL histone methyl-lysine binding protein 4

increases expression

ethyl-p-hydroxybenzoate results in increased expression of L3MBTL4 mRNA

NCBI chr 9:108,295,004...108,747,879
Ensembl chr 9:108,329,669...108,747,774

G

ladinin 1

increases expression

ethyl-p-hydroxybenzoate results in increased expression of LAD1 mRNA

NCBI chr13:47,249,605...47,263,967
Ensembl chr13:47,249,605...47,263,967

G

lymphocyte activating 3

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of LAG3 mRNA

NCBI chr 4:157,712,665...157,722,229
Ensembl chr 4:157,712,667...157,720,404

G

laminin subunit alpha 4

increases expression

ethyl-p-hydroxybenzoate results in increased expression of LAMA4 mRNA

NCBI chr20:42,392,268...42,533,347
Ensembl chr20:42,392,268...42,533,347

G

laminin subunit beta 3

increases expression

ethyl-p-hydroxybenzoate results in increased expression of LAMB3 mRNA

NCBI chr13:104,833,810...104,875,405
Ensembl chr13:104,833,873...104,875,405

G

laminin subunit gamma 2

increases expression

ethyl-p-hydroxybenzoate results in increased expression of LAMC2 mRNA

NCBI chr13:65,284,664...65,344,164
Ensembl chr13:65,284,664...65,344,200

G

lactate dehydrogenase D

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of LDHD mRNA

NCBI chr19:39,583,529...39,588,397
Ensembl chr19:39,573,621...39,595,575

G

leptin

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of LEP mRNA

NCBI chr 4:57,661,127...57,675,262
Ensembl chr 4:57,661,131...57,675,262

G

galectin 12

increases expression

ethyl-p-hydroxybenzoate results in increased expression of LGALS12 mRNA

NCBI chr 1:204,832,065...204,842,759
Ensembl chr 1:204,832,065...204,842,759

G

galectin 5

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of LGALS16 mRNA

NCBI chr10:63,853,949...63,857,198
Ensembl chr10:63,853,935...63,857,153

G

leucine rich repeat and Ig domain containing 3

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of LINGO3 mRNA

NCBI chr 7:8,869,025...8,878,431
Ensembl chr 7:8,869,025...8,878,431

G

lipase G, endothelial type

increases expression

ethyl-p-hydroxybenzoate results in increased expression of LIPG mRNA

NCBI chr18:68,514,923...68,536,105
Ensembl chr18:68,514,923...68,536,260

G

LIM homeobox transcription factor 1 beta

increases expression

ethyl-p-hydroxybenzoate results in increased expression of LMX1B mRNA

NCBI chr 3:16,862,195...16,940,899
Ensembl chr 3:16,862,195...16,940,899

G

lysyl oxidase

increases expression

ethyl-p-hydroxybenzoate results in increased expression of LOX mRNA

NCBI chr18:45,964,544...45,977,431
Ensembl chr18:45,967,343...46,041,477

G

lysyl oxidase-like 4

increases expression

ethyl-p-hydroxybenzoate results in increased expression of LOXL4 mRNA

NCBI chr 1:241,396,183...241,416,385
Ensembl chr 1:241,397,983...241,416,322

G

leucine rich repeat and fibronectin type III domain containing 1

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of LRFN1 mRNA

NCBI chr 1:83,742,442...83,761,450
Ensembl chr 1:83,682,964...83,761,449

G

leucine rich repeat and fibronectin type III domain containing 2

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of LRFN2 mRNA

NCBI chr 9:11,897,425...12,066,177
Ensembl chr 9:11,897,468...11,939,931

G

leucine-rich alpha-2-glycoprotein 1

increases expression

ethyl-p-hydroxybenzoate results in increased expression of LRG1 mRNA

NCBI chr 9:947,516...949,773
Ensembl chr 9:947,516...949,813

G

leucine rich repeat containing 15

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of LRRC15 mRNA

NCBI chr11:70,469,817...70,484,268
Ensembl chr11:70,469,804...70,484,267

G

leucine rich repeat containing 3

increases expression

ethyl-p-hydroxybenzoate results in increased expression of LRRC3 mRNA

NCBI chr20:10,758,919...10,763,736
Ensembl chr20:10,758,955...10,762,067

G

leucine rich repeat containing 4C

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of LRRC4C mRNA

NCBI chr 3:82,305,495...83,684,039
Ensembl chr 3:83,483,851...83,687,774

G

leucine-rich single-pass membrane protein 2

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of LSMEM2 mRNA

NCBI chr 8:108,265,855...108,270,656
Ensembl chr 8:108,266,345...108,279,115

G

lymphotoxin beta

increases expression

ethyl-p-hydroxybenzoate results in increased expression of LTB mRNA

NCBI chr20:3,627,536...3,629,381
Ensembl chr20:3,627,537...3,629,381

G

Ly6/Plaur domain containing 3

increases expression

ethyl-p-hydroxybenzoate results in increased expression of LYPD3 mRNA

NCBI chr 1:80,226,449...80,230,901
Ensembl chr 1:80,226,449...80,230,901

G

mab-21 like 4

increases expression

ethyl-p-hydroxybenzoate results in increased expression of MAB21L4 mRNA

NCBI chr 9:93,690,455...93,701,267
Ensembl chr 9:93,690,999...93,700,506

G

mal, T-cell differentiation protein

increases expression

ethyl-p-hydroxybenzoate results in increased expression of MAL mRNA

NCBI chr 3:114,864,378...114,888,136
Ensembl chr 3:114,864,378...114,888,136

G

MAM domain containing 2

increases expression

ethyl-p-hydroxybenzoate results in increased expression of MAMDC2 mRNA

NCBI chr 1:220,863,959...221,016,493
Ensembl chr 1:220,863,976...221,016,354

G

monoamine oxidase B

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of MAOB mRNA

NCBI chr X:5,907,327...6,010,996
Ensembl chr X:5,907,266...6,011,003

G

microtubule-associated protein tau

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of MAPT mRNA

NCBI chr10:89,138,644...89,236,137
Ensembl chr10:89,138,627...89,236,129

G

membrane associated ring-CH-type finger 10

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of MARCHF10 mRNA

NCBI chr10:90,332,783...90,423,109
Ensembl chr10:90,332,784...90,421,588

G

methionine adenosyltransferase 1A

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of MAT1A mRNA

NCBI chr16:16,983,084...17,001,284
Ensembl chr16:16,983,022...17,001,274

G

megakaryocyte-associated tyrosine kinase

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of MATK mRNA

NCBI chr 7:8,456,990...8,465,947
Ensembl chr 7:8,456,998...8,462,022

G

membrane bound O-acyltransferase domain containing 7

increases expression

ethyl-p-hydroxybenzoate results in increased expression of MBOAT7 mRNA

NCBI chr 1:65,525,206...65,539,538
Ensembl chr 1:65,525,213...65,539,538

G

multiple C2 and transmembrane domain containing 1

increases expression

ethyl-p-hydroxybenzoate results in increased expression of MCTP1 mRNA

NCBI chr 2:6,071,408...6,761,833
Ensembl chr 2:6,065,808...6,761,833

G

myocyte enhancer factor 2B

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of MEF2B mRNA

NCBI chr16:19,253,008...19,269,514
Ensembl chr16:19,253,010...19,268,967

G

multiple EGF-like-domains 11

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of MEGF11 mRNA

NCBI chr 8:64,892,312...65,218,984
Ensembl chr 8:64,892,387...65,216,061

G

meiosis specific with OB-fold

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of MEIOB mRNA

NCBI chr10:13,833,170...13,865,684
Ensembl chr10:13,833,750...13,865,046

G

methyltransferase like 27

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of METTL27 mRNA

NCBI chr12:21,757,545...21,766,698
Ensembl chr12:21,757,329...21,766,685

G

major facilitator superfamily domain containing 6-like

increases expression

ethyl-p-hydroxybenzoate results in increased expression of MFSD6L mRNA

NCBI chr10:53,258,794...53,260,887
Ensembl chr10:53,258,794...53,260,887

G

microsomal glutathione S-transferase 2

increases expression

ethyl-p-hydroxybenzoate results in increased expression of MGST2 mRNA

NCBI chr 2:135,679,524...135,715,828
Ensembl chr 2:135,693,557...135,715,828

G

midline 2

increases expression

ethyl-p-hydroxybenzoate results in increased expression of MID2 mRNA

NCBI chr X:104,354,692...104,456,757
Ensembl chr X:104,355,316...104,453,473

G

mitotic deacetylase associated SANT domain protein

increases expression

ethyl-p-hydroxybenzoate results in increased expression of MIDEAS mRNA

NCBI chr 6:103,784,779...103,854,470
Ensembl chr 6:103,787,873...103,829,178

G

major intrinsic protein of lens fiber

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of MIP mRNA

NCBI chr 7:643,502...653,121
Ensembl chr 7:647,315...654,400

G

microRNA 375

affects expression

ethyl-p-hydroxybenzoate affects the expression of MIR375

NCBI chr 9:76,457,911...76,457,985
Ensembl chr 9:76,457,911...76,457,985

G

monocyte to macrophage differentiation-associated 2

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of MMD2 mRNA

NCBI chr12:11,962,733...12,009,776
Ensembl chr12:11,962,757...12,009,773

G

matrix metallopeptidase 14

increases expression

ethyl-p-hydroxybenzoate results in increased expression of MMP14 mRNA

NCBI chr15:27,887,795...27,897,020
Ensembl chr15:27,887,727...27,899,864

G

matrix metallopeptidase 9

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of MMP9 protein

NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120

G

MORN repeat containing 5

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of MORN5 mRNA

NCBI chr 3:19,402,221...19,430,075
Ensembl chr 3:19,401,801...19,430,083

G

myelin protein zero-like 3

increases expression

ethyl-p-hydroxybenzoate results in increased expression of MPZL3 mRNA

NCBI chr 8:45,360,475...45,380,662
Ensembl chr 8:45,349,054...45,380,662

G

mannose receptor, C type 1

increases expression

ethyl-p-hydroxybenzoate results in increased expression of MRC1 mRNA

NCBI chr17:77,249,187...77,330,857
Ensembl chr17:77,249,187...77,330,857

G

MAS-related GPR, member B2

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of MRGPRX1 mRNA

NCBI chr 1:98,401,140...98,403,162
Ensembl chr 1:98,401,538...98,415,284

G

MTSS I-BAR domain containing 2

increases expression

ethyl-p-hydroxybenzoate results in increased expression of MTSS2 mRNA

NCBI chr19:38,692,793...38,714,575
Ensembl chr19:38,693,194...38,713,507

G

mucin 2, oligomeric mucus/gel-forming

increases expression

ethyl-p-hydroxybenzoate results in increased expression of MUC2 mRNA

NCBI chr 1:196,799,494...196,831,740
Ensembl chr 1:196,799,517...196,831,756

G

mucin 6, oligomeric mucus/gel-forming

increases expression

ethyl-p-hydroxybenzoate results in increased expression of MUC6 mRNA

NCBI chr 1:196,726,678...196,764,842
Ensembl chr 1:196,726,807...196,764,842

G

myeloid-associated differentiation marker-like 2

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of MYADML2 mRNA

NCBI chr10:105,922,557...105,927,867
Ensembl chr10:105,925,947...105,927,575

G

myosin binding protein C3

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of MYBPC3 mRNA

NCBI chr 3:77,095,165...77,113,406
Ensembl chr 3:77,095,252...77,113,405

G

Mycbp associated protein

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of MYCBPAP mRNA

NCBI chr10:79,450,319...79,470,977
Ensembl chr10:79,450,324...79,470,828

G

myosin heavy chain 11

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of MYH11 mRNA

NCBI chr10:743,364...838,459
Ensembl chr10:743,685...838,459

G

myosin heavy chain 2

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of MYH2 mRNA

NCBI chr10:51,856,738...51,883,236
Ensembl chr10:51,856,738...51,883,236

G

myosin light chain 7

increases expression

ethyl-p-hydroxybenzoate results in increased expression of MYL7 mRNA

NCBI chr14:80,780,684...80,783,259
Ensembl chr14:80,779,776...80,783,244

G

myosin XVA

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of MYO15A mRNA

NCBI chr10:45,277,619...45,335,953
Ensembl chr10:45,278,737...45,335,340

G

myelin regulatory factor-like

increases expression

ethyl-p-hydroxybenzoate results in increased expression of MYRFL mRNA

NCBI chr 7:52,403,324...52,519,907
Ensembl chr 7:52,403,650...52,519,907

G

myosin VIIA and Rab interacting protein

increases expression

ethyl-p-hydroxybenzoate results in increased expression of MYRIP mRNA

NCBI chr 8:120,017,749...120,184,821
Ensembl chr 8:120,017,524...120,183,833

G

NAC alpha domain containing

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of NACAD mRNA

NCBI chr14:81,465,299...81,473,866
Ensembl chr14:81,465,299...81,473,781

G

NALCN channel auxiliary factor 2

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of NALF2 mRNA

NCBI chr X:64,925,100...64,951,074
Ensembl chr X:64,925,051...64,951,077

G

N-acetyltransferase 8-like

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of NAT8L mRNA

NCBI chr14:76,756,077...76,762,712
Ensembl chr14:76,756,077...76,763,411

G

neural cell adhesion molecule 2

increases expression

ethyl-p-hydroxybenzoate results in increased expression of NCAM2 mRNA

NCBI chr11:20,104,974...20,592,168
Ensembl chr11:20,104,925...20,591,984

G

NCCRP1, F-box associated domain containing

increases expression

ethyl-p-hydroxybenzoate results in increased expression of NCCRP1 mRNA

NCBI chr 1:83,835,083...83,838,620
Ensembl chr 1:83,835,083...83,838,676

G

nuclear receptor coactivator 2

multiple interactions

ethyl-p-hydroxybenzoate inhibits the reaction [afimoxifene inhibits the reaction [ESRRG protein binds to NCOA2 protein]]

NCBI chr 5:5,835,642...6,069,693
Ensembl chr 5:5,835,706...6,067,451

G

natural cytotoxicity triggering receptor 3

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of NCR3 mRNA

NCBI chr20:3,637,242...3,643,748
Ensembl chr20:3,638,240...3,643,799

G

N-myc downstream regulated 1

increases expression

ethyl-p-hydroxybenzoate results in increased expression of NDRG1 mRNA

NCBI chr 7:98,684,487...98,725,869
Ensembl chr 7:98,684,487...98,725,880

G

NADH:ubiquinone oxidoreductase subunit A3

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of NDUFA3 mRNA

NCBI chr 1:65,597,567...65,600,197
Ensembl chr 1:65,597,578...65,600,235

G

N-terminal EF-hand calcium binding protein 2

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of NECAB2 mRNA

NCBI chr19:47,501,351...47,527,722
Ensembl chr19:47,501,302...47,527,684

G

neurogenin 2

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of NEUROG2 mRNA

NCBI chr 2:216,092,709...216,095,276
Ensembl chr 2:216,093,363...216,094,154

G

NFAT activating protein with ITAM motif 1

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of NFAM1 mRNA

NCBI chr 7:114,139,318...114,175,395
Ensembl chr 7:114,139,345...114,175,442

G

nerve growth factor

increases expression

ethyl-p-hydroxybenzoate results in increased expression of NGF mRNA

NCBI chr 2:189,901,058...189,954,452
Ensembl chr 2:189,901,058...189,954,452

G

niban apoptosis regulator 1

increases expression

ethyl-p-hydroxybenzoate results in increased expression of NIBAN1 mRNA

NCBI chr13:63,674,240...63,827,748
Ensembl chr13:63,674,171...63,827,729

G

Sodium/potassium transporting ATPase interacting 1

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of NKAIN1 mRNA

NCBI chr 5:142,747,702...142,792,665
Ensembl chr 5:142,747,505...142,791,863

G

Sodium/potassium transporting ATPase interacting 3

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of NKAIN3 mRNA

NCBI chr 5:33,613,720...34,310,090
Ensembl chr 5:33,623,713...34,309,381

G

neuroligin 3

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of NLGN3 mRNA

NCBI chr X:66,427,926...66,457,378
Ensembl chr X:66,429,458...66,451,876

G

NLR family, pyrin domain containing 10

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of NLRP10 mRNA

NCBI chr 1:162,922,806...162,930,363
Ensembl chr 1:162,922,806...162,930,363

G

nitric oxide synthase 1

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of NOS1 mRNA

NCBI chr12:38,615,111...38,795,492
Ensembl chr12:38,626,714...38,710,945

G

NADPH oxidase 3

increases expression

ethyl-p-hydroxybenzoate results in increased expression of NOX3 mRNA

NCBI chr 1:44,238,012...44,302,851
Ensembl chr 1:44,236,992...44,302,851

G

NPC1 like intracellular cholesterol transporter 1

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of NPC1L1 mRNA

NCBI chr14:81,071,448...81,091,113
Ensembl chr14:81,071,451...81,091,113

G

natriuretic peptide receptor 3

increases expression

ethyl-p-hydroxybenzoate results in increased expression of NPR3 mRNA

NCBI chr 2:60,865,483...60,933,432
Ensembl chr 2:60,870,594...60,932,955

G

nuclear receptor subfamily 0, group B, member 1

increases expression

ethyl-p-hydroxybenzoate results in increased expression of NR0B1 mRNA

NCBI chr X:50,756,886...50,761,014
Ensembl chr X:50,756,886...50,761,011

G

nuclear receptor subfamily 1, group I, member 2

increases expression

ethyl-p-hydroxybenzoate results in increased expression of NR1I2 mRNA

NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658

G

nuclear receptor subfamily 5, group A, member 1

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of NR5A1 mRNA

NCBI chr 3:22,464,786...22,486,328
Ensembl chr 3:22,465,502...22,486,328

G

neurensin 1

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of NRSN1 mRNA

NCBI chr17:39,806,238...39,824,550
Ensembl chr17:39,806,238...39,823,813

G

nuclear protein 1, transcriptional regulator

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of NUPR1 mRNA

NCBI chr 1:181,213,292...181,215,327
Ensembl chr 1:181,213,368...181,215,281

G

olfactomedin 2

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of OLFM2 mRNA

NCBI chr 8:19,204,472...19,282,154
Ensembl chr 8:19,204,475...19,282,117

G

opsin 1, short wave sensitive

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of OPN1SW mRNA

NCBI chr 4:57,977,317...57,980,457
Ensembl chr 4:57,977,313...57,980,457

G

opioid receptor, delta 1

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of OPRD1 mRNA

NCBI chr 5:144,306,188...144,340,960
Ensembl chr 5:144,306,188...144,340,960

G

opticin

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of OPTC mRNA

NCBI chr13:45,353,954...45,368,254
Ensembl chr13:45,355,148...45,365,237

G

olfactory receptor family 52 subfamily N member 4C

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of OR52N4 mRNA

NCBI chr 1:158,972,002...158,972,967
Ensembl chr 1:158,972,002...158,972,971

G

orosomucoid 1

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of ORM1 mRNA

NCBI chr 5:76,766,637...76,776,149
Ensembl chr 5:76,772,941...76,776,154

G

oncostatin M receptor

increases expression

ethyl-p-hydroxybenzoate results in increased expression of OSMR mRNA

NCBI chr 2:55,907,119...55,961,373
Ensembl chr 2:55,907,132...55,961,262

G

otoancorin

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of OTOA mRNA

NCBI chr 1:175,642,978...175,710,528
Ensembl chr 1:175,642,975...175,710,435

G

otoferlin

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of OTOF mRNA

NCBI chr 6:25,928,018...26,024,631
Ensembl chr 6:25,928,055...26,024,631

G

OVCA2 serine hydrolase domain containing

increases expression

ethyl-p-hydroxybenzoate results in increased expression of OVCA2 mRNA

NCBI chr10:60,026,048...60,029,211
Ensembl chr10:60,026,048...60,039,850

G

ovochymase 2

increases expression

ethyl-p-hydroxybenzoate results in increased expression of OVCH2 mRNA

NCBI chr 1:161,693,619...161,713,952
Ensembl chr 1:161,693,647...161,713,952

G

purinergic receptor P2X 3

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of P2RX3 mRNA

NCBI chr 3:70,080,850...70,124,664
Ensembl chr 3:70,080,851...70,125,178

G

purinergic receptor P2X 5

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of P2RX5 mRNA

NCBI chr10:57,777,737...57,789,426
Ensembl chr10:57,777,819...57,789,423

G

poly(A) binding protein, cytoplasmic 1-like 2A

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of PABPC1L2A mRNA

NCBI chr X:68,023,845...68,026,508

G

poly(A) binding protein cytoplasmic 1 like 2B

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of PABPC1L2B mRNA

G

p21 (RAC1) activated kinase 5

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of PAK5 mRNA

NCBI chr 3:123,395,678...123,703,967
Ensembl chr 3:123,396,497...123,703,930

G

paralemmin A kinase anchor protein

increases expression

ethyl-p-hydroxybenzoate results in increased expression of PALM2AKAP2 mRNA

NCBI chr 5:72,536,986...72,648,524
NCBI chr 5:72,313,646...72,450,645
Ensembl chr 5:72,181,718...72,648,524

G

paired box 8

increases expression

ethyl-p-hydroxybenzoate results in increased expression of PAX8 mRNA

NCBI chr 3:7,185,721...7,242,363
Ensembl chr 3:7,185,723...7,242,363

G

protocadherin alpha 12

increases expression

ethyl-p-hydroxybenzoate results in increased expression of PCDHA12 mRNA

Ensembl chr18:28,581,225...28,846,211

G

protocadherin alpha subfamily C, 1

increases expression

ethyl-p-hydroxybenzoate results in increased expression of PCDHAC1 mRNA

NCBI chr18:28,740,353...28,750,216
Ensembl chr18:28,581,225...28,846,211

G

protocadherin alpha subfamily C, 2

increases expression

ethyl-p-hydroxybenzoate results in increased expression of PCDHAC2 mRNA

Ensembl chr18:28,581,225...28,846,211

G

protocadherin beta 15

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of PCDHB7 mRNA

NCBI chr18:29,178,869...29,183,847
Ensembl chr18:29,181,052...29,183,804

G

protocadherin gamma subfamily C, 3

increases expression

ethyl-p-hydroxybenzoate results in increased expression of PCDHGC3 mRNA

NCBI chr18:29,633,016...29,667,865
Ensembl chr18:29,493,954...29,667,868

G

protocadherin gamma subfamily C, 5

increases expression

ethyl-p-hydroxybenzoate results in increased expression of PCDHGC5 mRNA

NCBI chr18:29,647,201...29,666,336
Ensembl chr18:29,493,954...29,667,868

G

phosphodiesterase 1B

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of PDE1B mRNA

NCBI chr 7:134,627,378...134,654,581
Ensembl chr 7:134,627,322...134,654,580

G

phosphodiesterase 7B

increases expression

ethyl-p-hydroxybenzoate results in increased expression of PDE7B mRNA

NCBI chr 1:15,174,001...15,493,267
Ensembl chr 1:15,182,704...15,492,900

G

platelet derived growth factor subunit B

increases expression

ethyl-p-hydroxybenzoate results in increased expression of PDGFB mRNA

NCBI chr 7:111,539,444...111,557,984
Ensembl chr 7:111,540,345...111,557,984

G

PDZ domain containing RING finger 4

increases expression

ethyl-p-hydroxybenzoate results in increased expression of PDZRN4 mRNA

NCBI chr 7:123,816,961...123,965,491
Ensembl chr 7:123,816,961...123,965,491

G

phosphoglucomutase 5

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of PGM5 mRNA

NCBI chr 1:222,325,638...222,513,434
Ensembl chr 1:222,325,643...222,513,437

G

progesterone receptor

increases expression
decreases expression

ethyl-p-hydroxybenzoate results in increased expression of PGR mRNA
ethyl-p-hydroxybenzoate results in decreased expression of PGR mRNA

PMID:34101200 PMID:35307500

NCBI chr 8:6,072,673...6,131,552
Ensembl chr 8:6,072,673...6,131,344

G

phosphatase and actin regulator 3

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of PHACTR3 mRNA

NCBI chr 3:165,205,247...165,423,692
Ensembl chr 3:165,205,255...165,423,153

G

phytanoyl-CoA dioxygenase domain containing 1

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of PHYHD1 mRNA

NCBI chr 3:13,535,670...13,553,797
Ensembl chr 3:13,540,056...13,553,797

G

phytanoyl-CoA 2-hydroxylase interacting protein

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of PHYHIP mRNA

NCBI chr15:45,533,974...45,545,223
Ensembl chr15:45,533,974...45,545,221

G

PILR alpha associated neural protein

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of PIANP mRNA

NCBI chr 4:157,796,425...157,804,842
Ensembl chr 4:157,798,808...157,804,842

G

plakophilin 1

increases expression

ethyl-p-hydroxybenzoate results in increased expression of PKP1 mRNA

NCBI chr13:47,309,607...47,357,432
Ensembl chr13:47,309,614...47,357,465

G

phospholipase A2, group IVF

increases expression

ethyl-p-hydroxybenzoate results in increased expression of PLA2G4F mRNA

NCBI chr 3:107,249,053...107,266,201
Ensembl chr 3:107,250,075...107,264,689

G

phospholipase C, eta 2

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of PLCH2 mRNA

NCBI chr 5:165,544,209...165,613,769
Ensembl chr 5:165,544,200...165,602,356

G

pleckstrin 2

increases expression

ethyl-p-hydroxybenzoate results in increased expression of PLEK2 mRNA

NCBI chr 6:97,700,123...97,719,417
Ensembl chr 6:97,701,106...97,719,326

G

pleckstrin homology domain containing N1

increases expression

ethyl-p-hydroxybenzoate results in increased expression of PLEKHN1 mRNA

NCBI chr 5:166,805,309...166,813,339
Ensembl chr 5:166,804,837...166,813,155

G

perilipin 4

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of PLIN4 mRNA

NCBI chr 9:929,168...938,062
Ensembl chr 9:929,176...938,056

G

PNMA family member 3

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of PNMA3 mRNA

NCBI chr X:150,906,080...150,912,674
Ensembl chr X:150,906,278...150,910,839

G

purine nucleoside phosphorylase

increases expression

ethyl-p-hydroxybenzoate results in increased expression of PNP mRNA

NCBI chr15:24,170,607...24,178,269
Ensembl chr15:24,170,602...24,203,986

G

podocan

increases expression

ethyl-p-hydroxybenzoate results in increased expression of PODN mRNA

NCBI chr 5:122,774,536...122,796,755
Ensembl chr 5:122,776,549...122,881,287

G

podocan-like 1

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of PODNL1 mRNA

NCBI chr19:24,027,261...24,033,867
Ensembl chr19:24,027,297...24,033,846

G

paraoxonase 3

increases expression

ethyl-p-hydroxybenzoate results in increased expression of PON3 mRNA

NCBI chr 4:33,356,983...33,383,681
Ensembl chr 4:33,349,168...33,383,855

G

peroxisome proliferator-activated receptor gamma

increases expression

ethyl-p-hydroxybenzoate results in increased expression of PPARG mRNA

NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468

G

protein phosphatase with EF-hand domain 1

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of PPEF1 mRNA

NCBI chr X:33,994,503...34,151,704
Ensembl chr X:34,021,350...34,151,701

G

protein phosphatase 3 catalytic subunit gamma

increases expression

ethyl-p-hydroxybenzoate results in increased expression of PPP3CC mRNA

NCBI chr15:45,289,917...45,362,012
Ensembl chr15:45,290,373...45,361,832

G

PML-RARA regulated adaptor molecule 1

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of PRAM1 mRNA

NCBI chr 7:14,428,548...14,438,081
Ensembl chr 7:14,420,165...14,438,166

G

proline and arginine rich end leucine rich repeat protein

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of PRELP mRNA

NCBI chr13:45,368,407...45,391,480
Ensembl chr13:45,370,533...45,380,270

G

protein kinase C, gamma

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of PRKCG mRNA

NCBI chr 1:65,832,851...65,860,676
Ensembl chr 1:65,832,855...65,859,384

G

protein arginine methyltransferase 8

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of PRMT8 mRNA

NCBI chr 4:160,535,813...160,618,193
Ensembl chr 4:160,535,813...160,617,930

G

protein interacting with cyclin A1

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of PROCA1 mRNA

NCBI chr10:63,090,018...63,102,941
Ensembl chr10:63,090,018...63,102,940

G

proline rich 9

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of PRR9 mRNA

NCBI chr 2:177,599,483...177,600,849
Ensembl chr 2:177,599,483...177,600,849

G

proline-rich transmembrane protein 1

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of PRRT1 mRNA

NCBI chr20:4,117,957...4,121,643
Ensembl chr20:4,117,957...4,121,600

G

proline-rich transmembrane protein 4

increases expression

ethyl-p-hydroxybenzoate results in increased expression of PRRT4 mRNA

NCBI chr 4:57,766,054...57,777,087
Ensembl chr 4:57,766,263...57,777,020

G

paired related homeobox 1

increases expression

ethyl-p-hydroxybenzoate results in increased expression of PRRX1 mRNA

NCBI chr13:75,600,777...75,671,896
Ensembl chr13:75,601,706...75,670,866

G

serine protease 22

increases expression

ethyl-p-hydroxybenzoate results in increased expression of PRSS22 mRNA

NCBI chr10:13,029,153...13,033,863
Ensembl chr10:13,029,153...13,033,863

G

serine protease 33

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of PRSS33 mRNA

NCBI chr10:12,858,941...12,861,281
Ensembl chr10:12,858,941...12,861,281

G

prosaposin-like 1

increases expression

ethyl-p-hydroxybenzoate results in increased expression of PSAPL1 mRNA

NCBI chr14:74,544,646...74,547,206
Ensembl chr14:74,544,646...74,547,206

G

prostate stem cell antigen

increases expression

ethyl-p-hydroxybenzoate results in increased expression of PSCA mRNA

NCBI chr 7:106,598,203...106,603,114
Ensembl chr 7:106,595,284...106,609,746

G

pleckstrin and Sec7 domain containing 2

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of PSD2 mRNA

NCBI chr18:27,564,912...27,616,674
Ensembl chr18:27,565,587...27,616,672

G

pleckstrin and Sec7 domain containing 4

increases expression

ethyl-p-hydroxybenzoate results in increased expression of PSD4 mRNA

NCBI chr 3:7,137,069...7,173,571
Ensembl chr 3:7,137,155...7,173,571

G

proline-serine-threonine phosphatase-interacting protein 1

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of PSTPIP1 mRNA

NCBI chr 8:56,499,287...56,538,593
Ensembl chr 8:56,499,590...56,538,580

G

protein tyrosine phosphatase, receptor type, M

increases expression

ethyl-p-hydroxybenzoate results in increased expression of PTPRM mRNA

NCBI chr 9:106,639,573...107,343,698
Ensembl chr 9:106,639,573...107,343,698

G

protein tyrosine phosphatase, receptor type N2

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of PTPRN2 mRNA

NCBI chr 6:137,439,572...138,191,575
Ensembl chr 6:137,439,540...138,191,575

G

PWWP domain containing 2B

increases expression

ethyl-p-hydroxybenzoate results in increased expression of PWWP2B mRNA

NCBI chr 1:194,040,395...194,059,979
Ensembl chr 1:194,041,341...194,059,958

G

PX domain containing serine/threonine kinase like

increases expression

ethyl-p-hydroxybenzoate results in increased expression of PXK mRNA

NCBI chr15:16,759,857...16,828,452
Ensembl chr15:16,759,862...16,828,444

G

pyroglutamylated RFamide peptide receptor

increases expression

ethyl-p-hydroxybenzoate results in increased expression of QRFPR mRNA

NCBI chr 2:119,053,083...119,096,864
Ensembl chr 2:119,053,511...119,096,792

G

receptor activity modifying protein 2

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of RAMP2 mRNA

NCBI chr10:86,187,366...86,190,692
Ensembl chr10:86,188,812...86,231,829

G

RASD family, member 2

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of RASD2 mRNA

NCBI chr19:13,594,291...13,605,016
Ensembl chr19:13,594,291...13,605,016

G

RasGEF domain family, member 1B

increases expression

ethyl-p-hydroxybenzoate results in increased expression of RASGEF1B mRNA

NCBI chr14:9,859,512...10,380,044
Ensembl chr14:9,860,247...10,379,741

G

RAS protein-specific guanine nucleotide-releasing factor 1

increases expression

ethyl-p-hydroxybenzoate results in increased expression of RASGRF1 mRNA

NCBI chr 8:90,445,154...90,574,274
Ensembl chr 8:90,445,154...90,574,269

G

RBBP8 N-terminal like

increases expression

ethyl-p-hydroxybenzoate results in increased expression of RBBP8NL mRNA

NCBI chr 3:167,364,048...167,378,993
Ensembl chr 3:167,364,048...167,379,092

G

ras homolog family member J

increases expression

ethyl-p-hydroxybenzoate results in increased expression of RHOJ mRNA

NCBI chr 6:94,035,307...94,117,642
Ensembl chr 6:94,035,483...94,118,275

G

regulating synaptic membrane exocytosis 4

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of RIMS4 mRNA

NCBI chr 3:152,520,982...152,585,070
Ensembl chr 3:152,524,095...152,584,780

G

RHO family interacting cell polarization regulator 1

increases expression

ethyl-p-hydroxybenzoate results in increased expression of RIPOR1 mRNA

NCBI chr19:33,477,750...33,506,424
Ensembl chr19:33,477,793...33,506,420

G

retinaldehyde binding protein 1

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of RLBP1 mRNA

NCBI chr 1:133,308,920...133,322,296
Ensembl chr 1:133,308,938...133,322,296

G

ring finger protein 112

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of RNF112 mRNA

NCBI chr10:46,121,146...46,126,691
Ensembl chr10:46,121,148...46,126,699

G

ring finger protein 152

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of RNF152 mRNA

NCBI chr13:21,324,039...21,403,405
Ensembl chr13:21,323,824...21,403,113

G

ring finger protein 43

increases expression

ethyl-p-hydroxybenzoate results in increased expression of RNF43 mRNA

NCBI chr10:72,461,508...72,537,301
Ensembl chr10:72,464,348...72,536,977

G

roundabout guidance receptor 2

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of ROBO2 mRNA

NCBI chr11:12,528,949...14,096,726
Ensembl chr11:12,528,951...13,041,536

G

R-spondin 1

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of RSPO1 mRNA

NCBI chr 5:137,251,629...137,273,273
Ensembl chr 5:137,251,659...137,272,933

G

R-spondin 4

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of RSPO4 mRNA

NCBI chr 3:140,357,256...140,391,780
Ensembl chr 3:140,357,424...140,388,254

G

RT1 class II, locus Db1

increases expression

ethyl-p-hydroxybenzoate results in increased expression of HLA-DRB1 mRNA

NCBI chr20:4,548,664...4,558,237
Ensembl chr20:4,548,666...4,558,258

G

RT1 class II, locus DMb

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of HLA-DMB mRNA

NCBI chr20:4,693,102...4,700,340
Ensembl chr20:4,693,103...4,700,340

G

retbindin

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of RTBDN mRNA

NCBI chr19:23,197,506...23,205,544
Ensembl chr19:23,197,506...23,204,438

G

retrotransposon-like 1

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of RTL1 mRNA

NCBI chr 6:128,543,904...128,549,384
Ensembl chr 6:128,543,939...128,549,182

G

retrotransposon Gag like 5

increases expression

ethyl-p-hydroxybenzoate results in increased expression of RTL5 mRNA

NCBI chr X:67,183,948...67,188,747
Ensembl chr X:67,184,154...67,188,809

G

RUN and FYVE domain containing 4

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of RUFY4 mRNA

NCBI chr 9:75,702,937...75,727,719
Ensembl chr 9:75,703,750...75,723,525

G

S100 calcium binding protein A3

increases expression

ethyl-p-hydroxybenzoate results in increased expression of S100A3 mRNA

NCBI chr 2:176,034,283...176,089,702
Ensembl chr 2:176,049,520...176,089,702

G

S100 calcium-binding protein A4

increases expression

ethyl-p-hydroxybenzoate results in increased expression of S100A4 mRNA

NCBI chr 2:176,090,951...176,093,258
Ensembl chr 2:176,091,804...176,093,254

G

S100 calcium binding protein A9

increases expression

ethyl-p-hydroxybenzoate results in increased expression of S100A9 mRNA

NCBI chr 2:176,190,361...176,193,182
Ensembl chr 2:176,190,361...176,193,230

G

sterile alpha motif domain containing 13

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of SAMD13 mRNA

NCBI chr 2:235,534,699...235,540,527
Ensembl chr 2:235,534,702...235,567,615

G

sarcosine dehydrogenase

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of SARDH mRNA

NCBI chr 3:10,510,553...10,575,342
Ensembl chr 3:10,510,553...10,573,874

G

SH3 domain binding kinase family, member 2

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of SBK2 mRNA

NCBI chr 1:68,874,081...68,881,918
Ensembl chr 1:68,874,152...68,881,916

G

SH3 domain binding kinase family, member 3

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of SBK3 mRNA

NCBI chr 1:68,867,847...68,873,249
Ensembl chr 1:68,868,238...68,871,392

G

sciellin

increases expression

ethyl-p-hydroxybenzoate results in increased expression of SCEL mRNA

NCBI chr15:80,339,661...80,456,546
Ensembl chr15:80,339,951...80,456,372

G

sodium voltage-gated channel alpha subunit 11

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of SCN11A mRNA

NCBI chr 8:119,495,550...119,567,044
Ensembl chr 8:119,496,769...119,567,044

G

sodium voltage-gated channel alpha subunit 4

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of SCN4A mRNA

NCBI chr10:91,246,936...91,296,670
Ensembl chr10:91,246,936...91,296,545

G

SEC14-like lipid binding 4

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of SEC14L4 mRNA

NCBI chr14:78,912,750...78,928,799
Ensembl chr14:78,912,750...78,956,099

G

SEC14-like lipid binding 5

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of SEC14L5 mRNA

NCBI chr10:10,394,963...10,436,076
Ensembl chr10:10,396,878...10,435,917

G

serpin family A member 5

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of SERPINA5 mRNA

NCBI chr 6:123,009,224...123,028,412
Ensembl chr 6:123,023,306...123,028,407

G

serpin family E member 3

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of SERPINE3 mRNA

NCBI chr15:36,908,816...36,931,825
Ensembl chr15:36,907,131...36,933,150

G

SERTA domain containing 4

increases expression

ethyl-p-hydroxybenzoate results in increased expression of SERTAD4 mRNA

NCBI chr13:104,360,307...104,371,064
Ensembl chr13:104,360,307...104,370,546

G

sarcoglycan, alpha

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of SGCA mRNA

NCBI chr10:79,904,698...79,922,808
Ensembl chr10:79,908,738...79,922,813

G

SH2 domain containing 3A

increases expression

ethyl-p-hydroxybenzoate results in increased expression of SH2D3A mRNA

NCBI chr 9:2,148,803...2,158,150

G

SH3 domain containing ring finger 3

increases expression

ethyl-p-hydroxybenzoate results in increased expression of SH3RF3 mRNA

NCBI chr20:26,765,278...27,099,261
Ensembl chr20:26,765,015...27,099,257

G

SH3 and multiple ankyrin repeat domains 1

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of SHANK1 mRNA

NCBI chr 1:94,807,879...94,857,356
Ensembl chr 1:94,808,276...94,855,824

G

SH2 domain containing adaptor protein B

increases expression

ethyl-p-hydroxybenzoate results in increased expression of SHB mRNA

NCBI chr 5:59,678,066...59,785,443
Ensembl chr 5:59,678,216...59,785,538

G

sex hormone binding globulin

affects binding

ethyl-p-hydroxybenzoate binds to SHBG protein

NCBI chr10:54,332,939...54,350,409
Ensembl chr10:54,332,941...54,351,057

G

shiftless antiviral inhibitor of ribosomal frameshifting

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of SHFL mRNA

NCBI chr 8:19,408,298...19,414,084
Ensembl chr 8:19,408,333...19,413,971

G

shisa family member 7

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of SHISA7 mRNA

NCBI chr 1:68,993,900...69,012,943
Ensembl chr 1:68,994,025...69,012,943

G

sialic acid binding Ig-like lectin 5

increases expression

ethyl-p-hydroxybenzoate results in increased expression of SIGLEC6 mRNA

NCBI chr 1:93,768,190...93,776,696
Ensembl chr 1:93,768,319...93,776,694

G

SIM bHLH transcription factor 2

increases expression

ethyl-p-hydroxybenzoate results in increased expression of SIM2 mRNA

NCBI chr11:33,414,218...33,453,663
Ensembl chr11:33,414,218...33,453,663

G

signaling threshold regulating transmembrane adaptor 1

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of SIT1 mRNA

NCBI chr 5:57,740,212...57,741,838
Ensembl chr 5:57,740,218...57,741,838

G

solute carrier family 13 member 4

increases expression

ethyl-p-hydroxybenzoate results in increased expression of SLC13A4 mRNA

NCBI chr 4:63,943,369...63,988,852
Ensembl chr 4:63,943,395...63,988,857

G

solute carrier family 17 member 7

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of SLC17A7 mRNA

NCBI chr 1:95,649,709...95,661,591
Ensembl chr 1:95,649,745...95,661,588

G

solute carrier family 1 member 4

increases expression

ethyl-p-hydroxybenzoate results in increased expression of SLC1A4 mRNA

NCBI chr14:94,530,801...94,560,190
Ensembl chr14:94,529,084...94,560,418

G

solute carrier family 24 member 4

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of SLC24A4 mRNA

NCBI chr 6:121,279,590...121,419,811
Ensembl chr 6:121,280,031...121,414,949

G

solute carrier family 26 member 5

increases expression

ethyl-p-hydroxybenzoate results in increased expression of SLC26A5 mRNA

NCBI chr 4:13,210,260...13,249,289
Ensembl chr 4:13,210,260...13,249,289

G

solute carrier family 30 member 3

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of SLC30A3 mRNA

NCBI chr 6:25,264,310...25,284,720
Ensembl chr 6:25,275,528...25,284,720

G

solute carrier family 34 member 2

increases expression

ethyl-p-hydroxybenzoate results in increased expression of SLC34A2 mRNA

NCBI chr14:57,910,931...57,930,236
Ensembl chr14:57,910,480...57,930,436

G

solute carrier family 39 member 2

increases expression

ethyl-p-hydroxybenzoate results in increased expression of SLC39A2 mRNA

NCBI chr15:24,590,738...24,592,850
Ensembl chr15:24,590,738...24,592,850

G

solute carrier family 45, member 3

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of SLC45A3 mRNA

NCBI chr13:43,407,293...43,427,588
Ensembl chr13:43,407,293...43,427,588

G

solute carrier family 46, member 3

increases expression

ethyl-p-hydroxybenzoate results in increased expression of SLC46A3 mRNA

NCBI chr12:7,140,610...7,157,093
Ensembl chr12:7,140,668...7,157,092

G

solute carrier family 5 member 5

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of SLC5A5 mRNA

NCBI chr16:18,546,709...18,556,698
Ensembl chr16:18,546,709...18,556,697

G

solute carrier family 6 member 1

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of SLC6A1 mRNA

NCBI chr 4:147,448,961...147,482,295
Ensembl chr 4:147,466,965...147,482,293

G

solute carrier family 6 member 11

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of SLC6A11 mRNA

NCBI chr 4:147,297,972...147,413,319
Ensembl chr 4:147,297,969...147,413,443

G

solute carrier family 6 member 4

increases expression

ethyl-p-hydroxybenzoate results in increased expression of SLC6A4 mRNA

NCBI chr10:61,824,208...61,858,924
Ensembl chr10:61,826,123...61,858,384

G

solute carrier family 9 member A2

increases expression

ethyl-p-hydroxybenzoate results in increased expression of SLC9A2 mRNA

NCBI chr 9:42,932,001...43,014,447
Ensembl chr 9:42,931,346...43,014,444

G

solute carrier family 9 member A5

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of SLC9A5 mRNA

NCBI chr19:33,225,481...33,246,913
Ensembl chr19:33,226,816...33,246,903

G

solute carrier organic anion transporter family, member 2a1

increases expression

ethyl-p-hydroxybenzoate results in increased expression of SLCO2A1 mRNA

NCBI chr 8:103,588,916...103,672,546
Ensembl chr 8:103,588,916...103,672,546

G

SLIT and NTRK-like family, member 3

increases expression

ethyl-p-hydroxybenzoate results in increased expression of SLITRK3 mRNA

NCBI chr 2:157,680,067...157,697,404
Ensembl chr 2:157,687,535...157,696,709

G

small integral membrane protein 11

increases expression

ethyl-p-hydroxybenzoate results in increased expression of SMIM11 mRNA

NCBI chr11:31,533,257...31,543,002
Ensembl chr11:31,532,764...31,543,002

G

small integral membrane protein 38

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of SMIM38 mRNA

NCBI chr 1:200,366,561...200,371,976

G

small integral membrane protein 5

increases expression

ethyl-p-hydroxybenzoate results in increased expression of SMIM5 mRNA

NCBI chr10:101,134,033...101,139,814
Ensembl chr10:101,134,033...101,139,813

G

sphingomyelin phosphodiesterase 1

increases expression

ethyl-p-hydroxybenzoate results in increased expression of SMPD1 mRNA

NCBI chr 1:159,892,946...159,896,789
Ensembl chr 1:159,892,859...159,896,794

G

synuclein, beta

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of SNCB mRNA

NCBI chr17:9,846,802...9,855,013
Ensembl chr17:9,846,802...9,855,012

G

sortilin-related VPS10 domain containing receptor 3

increases expression

ethyl-p-hydroxybenzoate results in increased expression of SORCS3 mRNA

NCBI chr 1:247,099,178...247,734,027
Ensembl chr 1:247,099,408...247,734,027

G

sosondowah ankyrin repeat domain family member B

increases expression

ethyl-p-hydroxybenzoate results in increased expression of SOWAHB mRNA

NCBI chr14:15,029,203...15,033,038
Ensembl chr14:15,029,395...15,031,698

G

SP140 nuclear body protein

increases expression

ethyl-p-hydroxybenzoate results in increased expression of SP140 mRNA

NCBI chr 9:86,224,472...86,274,724
Ensembl chr 9:86,224,513...86,274,542

G

sperm adhesion molecule 1

increases expression

ethyl-p-hydroxybenzoate results in increased expression of SPAM1 mRNA

NCBI chr 4:53,302,745...53,312,913
Ensembl chr 4:53,302,745...53,312,908

G

sperm microtubule inner protein 8

increases expression

ethyl-p-hydroxybenzoate results in increased expression of SPMIP8 mRNA

NCBI chr19:9,713,281...9,722,257
Ensembl chr19:9,712,641...9,722,257

G

SPARC/osteonectin, cwcv and kazal like domains proteoglycan 3

increases expression

ethyl-p-hydroxybenzoate results in increased expression of SPOCK3 mRNA

NCBI chr16:26,382,895...26,815,943
Ensembl chr16:26,383,383...26,815,205

G

spectrin, beta, erythrocytic

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of SPTB mRNA

NCBI chr 6:95,310,342...95,437,221
Ensembl chr 6:95,310,326...95,437,118

G

spectrin, beta, non-erythrocytic 4

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of SPTBN4 mRNA

NCBI chr 1:82,650,750...82,738,345
Ensembl chr 1:82,650,751...82,737,228

G

spectrin, beta, non-erythrocytic 5

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of SPTBN5 mRNA

NCBI chr 3:107,013,783...107,054,878
Ensembl chr 3:107,013,265...107,054,324

G

serine palmitoyltransferase, small subunit B

increases expression

ethyl-p-hydroxybenzoate results in increased expression of SPTSSB mRNA

NCBI chr 2:154,133,728...154,162,127
Ensembl chr 2:154,133,733...154,163,120

G

sushi-repeat-containing protein, X-linked 2

increases expression

ethyl-p-hydroxybenzoate results in increased expression of SRPX2 mRNA

NCBI chr X:97,106,455...97,132,197
Ensembl chr X:97,106,561...97,132,195

G

somatostatin receptor 3

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of SSTR3 mRNA

NCBI chr 7:110,092,563...110,109,043
Ensembl chr 7:110,092,575...110,099,769

G

SH3 and cysteine rich domain 2

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of STAC2 mRNA

NCBI chr10:83,032,418...83,048,260
Ensembl chr10:83,032,417...83,048,260

G

STAG3 cohesin complex component

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of STAG3 mRNA

NCBI chr12:17,284,677...17,314,936
Ensembl chr12:17,284,794...17,314,935

G

steroidogenic acute regulatory protein

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of STAR mRNA

NCBI chr16:66,267,094...66,274,368
Ensembl chr16:66,264,807...66,271,672

G

STEAP3 metalloreductase

increases expression

ethyl-p-hydroxybenzoate results in increased expression of STEAP3 mRNA

NCBI chr13:31,351,954...31,397,344
Ensembl chr13:31,351,954...31,396,519

G

stereocilin

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of STRC mRNA

NCBI chr 3:108,335,920...108,355,114
Ensembl chr 3:108,335,747...108,354,134

G

syntaxin 1B

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of STX1B mRNA

NCBI chr 1:182,415,544...182,434,385
Ensembl chr 1:182,415,546...182,441,280

G

synaptonemal complex central element protein 2

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of SYCE2 mRNA

NCBI chr19:23,266,236...23,291,265
Ensembl chr19:23,268,869...23,300,980

G

synapsin I

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of SYN1 mRNA

NCBI chr X:1,172,208...1,227,400
Ensembl chr X:1,172,208...1,227,396

G

synaptotagmin 3

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of SYT3 mRNA

NCBI chr 1:94,880,835...94,895,518
Ensembl chr 1:94,881,247...94,895,246

G

synaptotagmin 5

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of SYT5 mRNA

NCBI chr 1:69,277,351...69,285,071
Ensembl chr 1:69,277,351...69,285,067

G

synaptotagmin 9

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of SYT9 mRNA

NCBI chr 1:161,275,882...161,456,384
Ensembl chr 1:161,275,734...161,455,007

G

tachykinin receptor 1

increases expression

ethyl-p-hydroxybenzoate results in increased expression of TACR1 mRNA

NCBI chr 4:114,920,844...115,089,733
Ensembl chr 4:114,920,844...115,089,733

G

TBC1 domain family, member 2

increases expression

ethyl-p-hydroxybenzoate results in increased expression of TBC1D2 mRNA

NCBI chr 5:60,884,114...60,931,717
Ensembl chr 5:60,884,124...60,931,352

G

t-complex-associated testis expressed 1

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of TCTE1 mRNA

NCBI chr 9:15,463,573...15,482,258
Ensembl chr 9:15,463,739...15,472,954

G

transcription factor AP-2 beta

increases expression

ethyl-p-hydroxybenzoate results in increased expression of TFAP2B mRNA

NCBI chr 9:21,786,251...21,816,054
Ensembl chr 9:21,786,258...21,814,520

G

trefoil factor 1

increases expression

ethyl-p-hydroxybenzoate results in increased expression of TFF1 mRNA

NCBI chr20:9,235,736...9,239,597
Ensembl chr20:9,235,736...9,239,597

G

transforming growth factor, beta 1

increases expression

ethyl-p-hydroxybenzoate results in increased expression of TGFB1 mRNA

NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847

G

transforming growth factor beta 1 induced transcript 1

increases expression

ethyl-p-hydroxybenzoate results in increased expression of TGFB1I1 mRNA

NCBI chr 1:182,828,553...182,835,465
Ensembl chr 1:182,828,544...182,837,080

G

transforming growth factor, beta 3

increases expression

ethyl-p-hydroxybenzoate results in increased expression of TGFB3 mRNA

NCBI chr 6:105,704,058...105,726,661
Ensembl chr 6:105,704,236...105,726,564

G

transglutaminase 2

increases expression

ethyl-p-hydroxybenzoate results in increased expression of TGM2 mRNA

NCBI chr 3:146,772,684...146,801,924
Ensembl chr 3:146,772,687...146,801,981

G

thrombomodulin

increases expression

ethyl-p-hydroxybenzoate results in increased expression of THBD mRNA

NCBI chr 3:135,863,366...135,867,018
Ensembl chr 3:135,862,835...135,867,193

G

thrombospondin type 1 domain containing 1

increases expression

ethyl-p-hydroxybenzoate results in increased expression of THSD1 mRNA

NCBI chr16:69,771,408...69,804,844
Ensembl chr16:69,771,408...69,801,504

G

TLC domain containing 3B

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of TLCD3B mRNA

NCBI chr 1:181,421,104...181,439,744
Ensembl chr 1:181,422,830...181,439,743

G

TLE family member 6, subcortical maternal complex member

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of TLE6 mRNA

NCBI chr 7:8,107,050...8,118,639
Ensembl chr 7:8,107,207...8,118,639

G

TLE family member 7

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of TLE7 mRNA

NCBI chr19:38,072,682...38,084,942
Ensembl chr19:38,072,845...38,084,645

G

toll-like receptor 2

increases expression

ethyl-p-hydroxybenzoate results in increased expression of TLR2 mRNA

NCBI chr 2:169,200,620...169,206,819
Ensembl chr 2:169,197,419...169,206,630

G

toll-like receptor 4

increases expression

ethyl-p-hydroxybenzoate results in increased expression of TLR4 mRNA

NCBI chr 5:80,145,867...80,159,501
Ensembl chr 5:80,145,826...80,159,628

G

toll-like receptor 6

increases expression

ethyl-p-hydroxybenzoate results in increased expression of TLR6 mRNA

NCBI chr14:43,362,164...43,374,500
Ensembl chr14:43,362,164...43,375,685

G

transmembrane 4 L six family member 1

increases expression

ethyl-p-hydroxybenzoate results in increased expression of TM4SF1 mRNA

NCBI chr 2:141,456,950...141,466,146
Ensembl chr 2:141,453,310...141,466,146

G

transmembrane protein 114

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of TMEM114 mRNA

NCBI chr10:7,168,998...7,185,251
Ensembl chr10:7,169,746...7,185,251

G

transmembrane protein 151B

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of TMEM151B mRNA

NCBI chr 9:15,456,446...15,464,289
Ensembl chr 9:15,455,801...15,464,302

G

transmembrane protein 179

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of TMEM179 mRNA

NCBI chr 6:131,569,289...131,580,413
Ensembl chr 6:131,569,290...131,580,305

G

transmembrane protein 184A

increases expression

ethyl-p-hydroxybenzoate results in increased expression of TMEM184A mRNA

NCBI chr12:14,817,508...14,833,109
Ensembl chr12:14,822,898...14,832,065

G

transmembrane protein 200B

increases expression

ethyl-p-hydroxybenzoate results in increased expression of TMEM200B mRNA

NCBI chr 5:144,107,795...144,110,551
Ensembl chr 5:144,103,550...144,112,506

G

transmembrane protein 40

increases expression

ethyl-p-hydroxybenzoate results in increased expression of TMEM40 mRNA

NCBI chr 4:148,791,509...148,819,287
Ensembl chr 4:148,791,505...148,823,665

G

transmembrane serine protease 11F

increases expression

ethyl-p-hydroxybenzoate results in increased expression of TMPRSS11F mRNA

NCBI chr14:21,492,896...21,534,792
Ensembl chr14:21,429,418...21,534,809

G

transmembrane serine protease 3

increases expression

ethyl-p-hydroxybenzoate results in increased expression of TMPRSS3 mRNA

NCBI chr20:9,254,102...9,273,808
Ensembl chr20:9,254,109...9,274,363

G

TNF receptor superfamily member 11B

increases expression

ethyl-p-hydroxybenzoate results in increased expression of TNFRSF11B mRNA

NCBI chr 7:85,566,520...85,594,526
Ensembl chr 7:85,566,520...85,594,538

G

TNF receptor superfamily member 1B

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of TNFRSF1B mRNA

NCBI chr 5:157,070,642...157,104,216
Ensembl chr 5:157,070,642...157,104,206

G

TNF receptor superfamily member 21

increases expression

ethyl-p-hydroxybenzoate results in increased expression of TNFRSF21 mRNA

NCBI chr 9:17,879,156...17,954,085
Ensembl chr 9:17,879,156...17,954,085

G

TNFAIP3 interacting protein 3

increases expression

ethyl-p-hydroxybenzoate results in increased expression of TNIP3 mRNA

NCBI chr 4:94,867,258...94,908,780
Ensembl chr 4:94,811,097...94,907,605

G

tenascin N

increases expression

ethyl-p-hydroxybenzoate results in increased expression of TNN mRNA

NCBI chr13:72,319,160...72,386,362
Ensembl chr13:72,319,155...72,408,156

G

tensin 2

increases expression

ethyl-p-hydroxybenzoate results in increased expression of TNS2 mRNA

NCBI chr 7:133,229,746...133,247,889
Ensembl chr 7:133,206,364...133,247,888

G

TNFRSF1A-associated via death domain

increases expression

ethyl-p-hydroxybenzoate results in increased expression of TRADD mRNA

NCBI chr19:33,136,148...33,142,714
Ensembl chr19:33,136,138...33,142,638

G

triggering receptor expressed on myeloid cells-like 2

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of TREML2 mRNA

NCBI chr 9:12,694,453...12,705,379
Ensembl chr 9:12,694,697...12,705,324

G

tripartite motif-containing 69

increases expression

ethyl-p-hydroxybenzoate results in increased expression of TRIM69 mRNA

NCBI chr 3:109,111,468...109,135,255
Ensembl chr 3:109,111,468...109,132,037

G

transient receptor potential cation channel, subfamily M, member 2

increases expression

ethyl-p-hydroxybenzoate results in increased expression of TRPM2 mRNA

NCBI chr20:10,703,568...10,753,189
Ensembl chr20:10,707,014...10,753,181

G

transient receptor potential cation channel, subfamily V, member 6

increases expression

ethyl-p-hydroxybenzoate results in increased expression of TRPV6 mRNA

NCBI chr 4:70,507,347...70,523,013
Ensembl chr 4:70,507,348...70,523,017

G

testis specific 10 interacting protein

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of TSGA10IP mRNA

NCBI chr 1:202,700,576...202,714,668
Ensembl chr 1:202,700,578...202,714,798

G

teashirt zinc finger homeobox 2

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of TSHZ2 mRNA

NCBI chr 3:158,405,469...158,666,915
Ensembl chr 3:158,405,423...158,850,128

G

thymic stromal lymphopoietin

increases expression

ethyl-p-hydroxybenzoate results in increased expression of TSLP mRNA

NCBI chr18:24,447,409...24,454,244
Ensembl chr18:24,449,844...24,453,548

G

thrombospondin-type laminin G domain and EAR repeats

increases expression

ethyl-p-hydroxybenzoate results in increased expression of TSPEAR mRNA

NCBI chr20:10,771,806...10,837,419
Ensembl chr20:10,772,219...10,943,914

G

tau tubulin kinase 1

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of TTBK1 mRNA

NCBI chr 9:14,493,166...14,538,372
Ensembl chr 9:14,493,389...14,535,774

G

tubulin tyrosine ligase like11

increases expression

ethyl-p-hydroxybenzoate results in increased expression of TTLL11 mRNA

NCBI chr 3:19,109,891...19,335,077
Ensembl chr 3:19,110,284...19,335,969

G

tubulin tyrosine ligase like 6

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of TTLL6 mRNA

NCBI chr10:81,081,985...81,118,009
Ensembl chr10:81,091,975...81,127,234

G

tubulin, beta 3 class III

increases expression

ethyl-p-hydroxybenzoate results in increased expression of TUBB3 mRNA

NCBI chr19:51,457,187...51,466,243
Ensembl chr19:51,457,184...51,466,243

G

tubulin, beta 4A class IVa

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of TUBB4A mRNA

NCBI chr 9:1,917,841...1,925,286
Ensembl chr 9:1,917,845...1,925,291

G

tyrosinase

affects response to substance

TYR protein affects the susceptibility to ethyl-p-hydroxybenzoate

NCBI chr 1:141,115,036...141,210,207
Ensembl chr 1:141,115,036...141,210,207

G

UDP-N-acetylglucosamine pyrophosphorylase 1 like 1

increases expression

ethyl-p-hydroxybenzoate results in increased expression of UAP1L1 mRNA

NCBI chr 3:8,172,335...8,180,505
Ensembl chr 3:8,173,216...8,180,443

G

ubiquitin-like modifier activating enzyme 7

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of UBA7 mRNA

NCBI chr 8:108,665,289...108,674,097
Ensembl chr 8:108,665,292...108,674,099

G

urocortin 2

increases expression

ethyl-p-hydroxybenzoate results in increased expression of UCN2 mRNA

NCBI chr 8:109,637,624...109,639,173
Ensembl chr 8:109,638,285...109,639,172

G

uncoupling protein 1

increases expression

ethyl-p-hydroxybenzoate results in increased expression of UCP1 mRNA

NCBI chr19:24,808,782...24,816,853
Ensembl chr19:24,808,783...24,816,852

G

uroplakin 1A

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of UPK1A mRNA

NCBI chr 1:85,859,672...85,870,147
Ensembl chr 1:85,859,671...85,870,354

G

uroplakin 2

increases expression

ethyl-p-hydroxybenzoate results in increased expression of UPK2 mRNA

NCBI chr 8:44,779,198...44,781,190
Ensembl chr 8:44,779,198...44,781,190

G

uroplakin 3B like 1

increases expression

ethyl-p-hydroxybenzoate results in increased expression of UPK3BL1 mRNA

NCBI chr12:20,610,353...20,616,366
Ensembl chr12:20,610,353...20,616,366

G

ventral anterior homeobox 2

increases expression

ethyl-p-hydroxybenzoate results in increased expression of VAX2 mRNA

NCBI chr 4:116,195,528...116,219,597
Ensembl chr 4:116,195,528...116,219,594

G

von Willebrand factor A domain containing 1

increases expression

ethyl-p-hydroxybenzoate results in increased expression of VWA1 mRNA

NCBI chr 5:166,377,451...166,382,784
Ensembl chr 5:166,377,455...166,382,637

G

von Willebrand factor A domain containing 5B2

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of VWA5B2 mRNA

NCBI chr11:80,306,067...80,323,220
Ensembl chr11:80,306,350...80,323,220

G

Wnt family member 2

increases expression

ethyl-p-hydroxybenzoate results in increased expression of WNT2 mRNA

NCBI chr 4:46,328,408...46,374,673
Ensembl chr 4:46,333,998...46,374,402

G

Wnt family member 3A

increases expression

ethyl-p-hydroxybenzoate results in increased expression of WNT3A mRNA

NCBI chr10:44,034,174...44,078,366
Ensembl chr10:44,034,194...44,078,324

G

Wnt family member 7A

increases expression

ethyl-p-hydroxybenzoate results in increased expression of WNT7A mRNA

NCBI chr 4:123,863,108...123,908,981
Ensembl chr 4:123,863,108...123,908,981

G

Wnt family member 7B

increases expression

ethyl-p-hydroxybenzoate results in increased expression of WNT7B mRNA

NCBI chr 7:116,634,817...116,679,459
Ensembl chr 7:116,634,814...116,679,581

G

Wnt family member 9B

increases expression

ethyl-p-hydroxybenzoate results in increased expression of WNT9B mRNA

NCBI chr10:88,635,330...88,657,035
Ensembl chr10:88,635,331...88,657,035

G

X-prolyl aminopeptidase 2

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of XPNPEP2 mRNA

NCBI chr X:127,287,765...127,317,036
Ensembl chr X:127,287,979...127,317,223

G

Y box binding protein 2

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of YBX2 mRNA

NCBI chr10:54,659,719...54,665,371
Ensembl chr10:54,659,719...54,665,371

G

zinc finger protein 488

increases expression

ethyl-p-hydroxybenzoate results in increased expression of ZNF488 mRNA

NCBI chr16:9,283,039...9,293,681
Ensembl chr16:9,283,043...9,293,671

G

zinc finger protein 536

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of ZNF536 mRNA

NCBI chr 1:90,000,359...90,463,423
Ensembl chr 1:90,002,858...90,462,990

G

Zic family member 4

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of ZIC4 mRNA

NCBI chr 8:91,916,356...91,936,525
Ensembl chr 8:91,920,015...91,935,368

G

zinc finger, MYND-type containing 15

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of ZMYND15 mRNA

NCBI chr10:55,171,198...55,177,812
Ensembl chr10:55,171,198...55,177,812

G

zona pellucida glycoprotein 3

decreases expression

ethyl-p-hydroxybenzoate results in decreased expression of ZP3 mRNA

NCBI chr12:20,690,547...20,697,513
Ensembl chr12:20,690,547...20,697,513

G

zinc finger and SCAN domain containing 4F

increases expression

ethyl-p-hydroxybenzoate results in increased expression of ZSCAN4 mRNA

NCBI chr 7:13,759,115...13,762,279
Ensembl chr 7:13,759,115...13,762,279

Isobutylparaben

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

androgen receptor

affects binding

isobutylparaben binds to AR protein

NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925

G

estrogen receptor 1

multiple interactions
affects binding

isobutylparaben binds to and results in increased activity of ESR1 protein
isobutyl-4-hydroxybenzoate binds to ESR1 protein; isobutylparaben metabolite binds to ESR1 protein
isobutylparaben binds to ESR1 protein

PMID:11193391 PMID:20132880 PMID:23567241 PMID:29945225

NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002

G

estrogen receptor 2

multiple interactions
affects binding

isobutylparaben binds to and results in increased activity of ESR2 protein
isobutyl-4-hydroxybenzoate binds to ESR2 protein
isobutylparaben binds to ESR2 protein

PMID:11193391 PMID:20132880 PMID:23567241

NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919

G

growth regulating estrogen receptor binding 1

multiple interactions
increases expression

Fulvestrant inhibits the reaction [isobutylparaben metabolite results in increased expression of GREB1 mRNA]; Fulvestrant inhibits the reaction [isobutylparaben results in increased expression of GREB1 mRNA]
isobutylparaben metabolite results in increased expression of GREB1 mRNA; isobutylparaben results in increased expression of GREB1 mRNA

NCBI chr 6:39,440,522...39,562,364
Ensembl chr 6:39,440,504...39,581,633

G

nuclear receptor subfamily 1, group I, member 2

increases expression

isobutylparaben results in increased expression of NR1I2 mRNA

NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658

G

nuclear receptor subfamily 1, group I, member 3

increases activity
increases expression

isobutyl-4-hydroxybenzoate results in increased activity of NR1I3 protein
isobutylparaben results in increased expression of NR1I3 mRNA

PMID:28927721 PMID:31472229

NCBI chr13:83,632,940...83,638,193
Ensembl chr13:83,632,899...83,637,906

G

progesterone receptor

increases expression
multiple interactions

isobutylparaben results in increased expression of PGR protein
[isobutylparaben co-treated with bisphenol A] results in increased expression of PGR mRNA; [isobutylparaben co-treated with bisphenol A] results in increased expression of PGR protein; Fulvestrant inhibits the reaction [isobutylparaben results in increased expression of PGR protein]

NCBI chr 8:6,072,673...6,131,552
Ensembl chr 8:6,072,673...6,131,344

G

S100 calcium binding protein G

multiple interactions
increases expression

[isobutylparaben co-treated with bisphenol A] results in increased expression of S100G mRNA; [isobutylparaben co-treated with bisphenol A] results in increased expression of S100G protein; Fulvestrant inhibits the reaction [isobutylparaben results in increased expression of S100G protein]
isobutylparaben results in increased expression of S100G mRNA; isobutylparaben results in increased expression of S100G protein

PMID:19654335 PMID:23211298

NCBI chr X:31,705,853...31,708,422
Ensembl chr X:31,705,866...31,708,433

G

stathmin 1

increases expression

isobutyl-4-hydroxybenzoate results in increased expression of STMN1 protein

NCBI chr 5:146,680,757...146,687,154
Ensembl chr 5:146,681,436...146,687,154

Isopropylparaben

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

estrogen receptor 1

decreases expression
affects binding
multiple interactions

isopropyl 4-hydroxybenzoate results in decreased expression of ESR1 mRNA; isopropyl 4-hydroxybenzoate results in decreased expression of ESR1 protein
isopropyl 4-hydroxybenzoate binds to ESR1 protein
Fulvestrant inhibits the reaction [isopropyl 4-hydroxybenzoate results in decreased expression of ESR1 mRNA]; Fulvestrant inhibits the reaction [isopropyl 4-hydroxybenzoate results in decreased expression of ESR1 protein]

PMID:11193391 PMID:19654335

NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002

G

estrogen receptor 2

affects binding

isopropyl 4-hydroxybenzoate binds to ESR2 protein

NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919

G

progesterone receptor

increases expression
multiple interactions

isopropyl 4-hydroxybenzoate results in increased expression of PGR mRNA; isopropyl 4-hydroxybenzoate results in increased expression of PGR protein
Fulvestrant inhibits the reaction [isopropyl 4-hydroxybenzoate results in increased expression of PGR mRNA]; Fulvestrant inhibits the reaction [isopropyl 4-hydroxybenzoate results in increased expression of PGR protein]

NCBI chr 8:6,072,673...6,131,552
Ensembl chr 8:6,072,673...6,131,344

G

S100 calcium binding protein G

multiple interactions
increases expression

Fulvestrant inhibits the reaction [isopropyl 4-hydroxybenzoate results in increased expression of S100G mRNA]; Fulvestrant inhibits the reaction [isopropyl 4-hydroxybenzoate results in increased expression of S100G protein]
isopropyl 4-hydroxybenzoate results in increased expression of S100G mRNA; isopropyl 4-hydroxybenzoate results in increased expression of S100G protein

NCBI chr X:31,705,853...31,708,422
Ensembl chr X:31,705,866...31,708,433

methylparaben

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

alanyl-tRNA synthetase 1

increases expression

methylparaben results in increased expression of AARS1 mRNA

NCBI chr19:38,999,130...39,021,152
Ensembl chr19:38,999,163...39,021,147

G

alanyl-tRNA synthetase 2, mitochondrial

increases expression

methylparaben results in increased expression of AARS2 mRNA

NCBI chr 9:15,484,639...15,496,116
Ensembl chr 9:15,297,531...15,496,090

G

ATP binding cassette subfamily E member 1

decreases expression

methylparaben results in decreased expression of ABCE1 mRNA

NCBI chr19:28,205,566...28,230,489
Ensembl chr19:28,205,555...28,230,489

G

acyl-CoA binding domain containing 7

decreases expression

methylparaben results in decreased expression of ACBD7 mRNA

NCBI chr17:74,903,936...74,909,977
Ensembl chr17:74,903,177...74,905,811

G

acyl-CoA synthetase long-chain family member 6

increases expression

methylparaben results in increased expression of ACSL6 mRNA

NCBI chr10:38,439,914...38,501,182
Ensembl chr10:38,440,080...38,498,757

G

acyl-CoA synthetase short-chain family member 2

increases expression

methylparaben results in increased expression of ACSS2 mRNA

NCBI chr 3:144,003,808...144,047,452
Ensembl chr 3:144,004,336...144,059,675

G

actin-related protein T3

decreases expression

methylparaben results in decreased expression of ACTRT3 mRNA

NCBI chr 2:112,799,038...112,801,065
Ensembl chr 2:112,799,011...112,801,075

G

adenosine deaminase, tRNA-specific 2

decreases expression

methylparaben results in decreased expression of ADAT2 mRNA

NCBI chr 1:7,954,520...7,975,254
Ensembl chr 1:7,954,631...7,975,251

G

alcohol dehydrogenase 5 (class III), chi polypeptide

decreases expression

methylparaben results in decreased expression of ADH5 mRNA

NCBI chr 2:226,975,184...226,987,591
Ensembl chr 2:226,947,466...226,987,591

G

1-acylglycerol-3-phosphate O-acyltransferase 5

increases expression

methylparaben results in increased expression of AGPAT5 mRNA

NCBI chr16:70,939,480...70,985,745
Ensembl chr16:70,943,135...70,985,560

G

AHNAK nucleoprotein

decreases expression

methylparaben results in decreased expression of AHNAK mRNA

NCBI chr 1:205,882,225...205,970,934
Ensembl chr 1:205,882,273...205,970,926

G

A-kinase anchoring protein 12

decreases expression

methylparaben results in decreased expression of AKAP12 mRNA

NCBI chr 1:40,730,123...40,819,863
Ensembl chr 1:40,730,123...40,819,886

G

aldo-keto reductase family 1, member C1

decreases expression

methylparaben results in decreased expression of AKR1C1 mRNA

NCBI chr17:65,810,474...65,837,385
Ensembl chr17:65,810,475...65,837,326

G

aldo-keto reductase family 1, member C2

decreases expression

methylparaben results in decreased expression of AKR1C2 mRNA

NCBI chr17:65,759,778...65,808,013
Ensembl chr17:65,759,788...65,775,764

G

aldo-keto reductase family 1, member C3

decreases expression

methylparaben results in decreased expression of AKR1C3 mRNA

NCBI chr17:66,110,970...66,127,867
Ensembl chr17:66,110,963...66,127,873

G

AKT serine/threonine kinase 1

increases expression

methylparaben results in increased expression of AKT1 mRNA

NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921

G

aldehyde dehydrogenase 1 family, member A1

increases expression

methylparaben results in increased expression of ALDH1A1 mRNA

NCBI chr 1:218,000,470...218,152,962
Ensembl chr 1:218,042,127...218,152,961

G

aldehyde dehydrogenase 1 family, member A2

decreases expression

methylparaben results in decreased expression of ALDH1A2 mRNA

NCBI chr 8:71,877,850...71,957,107
Ensembl chr 8:71,877,850...71,957,107

G

aldehyde dehydrogenase 3 family, member A1

decreases expression

methylparaben results in decreased expression of ALDH3A1 mRNA

NCBI chr10:45,892,993...45,902,680
Ensembl chr10:45,892,924...45,902,681

G

aldolase, fructose-bisphosphate C

decreases expression

methylparaben results in decreased expression of ALDOC mRNA

NCBI chr10:63,217,477...63,221,066
Ensembl chr10:63,217,451...63,221,066

G

alkB homolog 8, tRNA methyltransferase

decreases expression

methylparaben results in decreased expression of ALKBH8 mRNA

NCBI chr 6:378,779...449,382
Ensembl chr 6:378,100...452,165

G

alpha-kinase 1

increases expression

methylparaben results in increased expression of ALPK1 mRNA

NCBI chr 2:216,126,939...216,247,180
Ensembl chr 2:216,128,825...216,247,157

G

alkaline phosphatase, biomineralization associated

decreases expression

methylparaben results in decreased expression of ALPL mRNA

NCBI chr 5:149,951,397...150,006,424
Ensembl chr 5:149,951,409...150,006,446

G

Aly/REF export factor

increases expression

methylparaben results in increased expression of ALYREF mRNA

NCBI chr10:105,871,424...105,875,076
Ensembl chr10:105,871,306...105,875,069

G

angiomotin like 2

increases expression

methylparaben results in increased expression of AMOTL2 mRNA

NCBI chr 8:103,303,368...103,319,161
Ensembl chr 8:103,302,992...103,318,910

G

anaphase-promoting complex subunit 5

increases expression

methylparaben results in increased expression of ANAPC5 mRNA

NCBI chr12:33,748,709...33,781,709
Ensembl chr12:33,748,735...33,781,781

G

angel homolog 2

increases expression

methylparaben results in increased expression of ANGEL2 mRNA

NCBI chr13:102,509,111...102,529,501
Ensembl chr13:102,510,589...102,529,493

G

angiopoietin-like 4

increases expression

methylparaben results in increased expression of ANGPTL4 mRNA

NCBI chr 7:14,550,288...14,557,797
Ensembl chr 7:14,550,311...14,556,519

G

annexin A1

decreases expression

methylparaben results in decreased expression of ANXA1 mRNA

NCBI chr 1:217,861,175...217,877,205
Ensembl chr 1:217,861,175...217,877,343

G

annexin A4

decreases expression

methylparaben results in decreased expression of ANXA4 mRNA

NCBI chr 4:119,184,378...119,241,183
Ensembl chr 4:119,184,374...119,241,161

G

adaptor related protein complex 1 subunit sigma 2

decreases expression

methylparaben results in decreased expression of AP1S2 mRNA

NCBI chr X:30,572,746...30,598,961
Ensembl chr X:30,572,751...30,597,262

G

adaptor related protein complex 1 subunit sigma 3

decreases expression

methylparaben results in decreased expression of AP1S3 mRNA

NCBI chr 9:80,950,402...81,009,889
Ensembl chr 9:80,950,715...81,009,798

G

adaptor related protein complex 5 subunit beta 1

increases expression

methylparaben results in increased expression of AP5B1 mRNA

NCBI chr 1:202,876,272...202,880,303
Ensembl chr 1:202,876,272...202,880,289

G

aph-1 homolog B, gamma secretase subunit

decreases expression

methylparaben results in decreased expression of APH1B mRNA

NCBI chr 8:67,429,198...67,454,735
Ensembl chr 8:67,429,198...67,450,243

G

Rho GTPase activating protein 11A

decreases expression
increases expression

methylparaben results in decreased expression of ARHGAP11A mRNA
methylparaben results in increased expression of ARHGAP11A mRNA

PMID:31745603 PMID:38568856

NCBI chr 3:100,590,865...100,607,146
Ensembl chr 3:100,590,865...100,607,559

G

Rho GTPase activating protein 9

increases expression

methylparaben results in increased expression of ARHGAP9 mRNA

NCBI chr 7:63,148,573...63,157,025
Ensembl chr 7:63,148,900...63,157,524

G

ARF like GTPase 4A

decreases expression

methylparaben results in decreased expression of ARL4A mRNA

NCBI chr 6:57,079,496...57,084,156
Ensembl chr 6:57,078,812...57,085,066

G

actin related protein 2/3 complex, subunit 2

increases expression

methylparaben results in increased expression of ARPC2 mRNA

NCBI chr 9:75,820,782...75,851,471
Ensembl chr 9:75,820,770...75,851,471

G

arylsulfatase family, member K

increases expression

methylparaben results in increased expression of ARSK mRNA

NCBI chr 2:5,574,319...5,631,451
Ensembl chr 2:5,574,322...5,631,467

G

anti-silencing function 1A histone chaperone

decreases expression

methylparaben results in decreased expression of ASF1A mRNA

NCBI chr20:32,893,962...32,908,808
Ensembl chr20:32,893,573...32,908,808

G

asparagine synthetase (glutamine-hydrolyzing)

increases expression

methylparaben results in increased expression of ASNS mRNA

NCBI chr 4:35,784,995...35,803,474
Ensembl chr 4:35,785,237...35,803,423

G

aspartate-beta-hydroxylase

increases expression

methylparaben results in increased expression of ASPH mRNA

NCBI chr 5:22,601,581...22,814,107
Ensembl chr 5:22,603,486...22,813,876

G

argininosuccinate synthase 1

decreases expression

methylparaben results in decreased expression of ASS1 mRNA

NCBI chr 3:14,747,355...14,796,909
Ensembl chr 3:14,747,368...14,796,903

G

ATPase family, AAA domain containing 2

increases expression

methylparaben results in increased expression of ATAD2 mRNA

NCBI chr 7:89,634,123...89,676,738
Ensembl chr 7:89,634,123...89,676,738

G

activating transcription factor 3

increases expression

methylparaben results in increased expression of ATF3 mRNA

NCBI chr13:102,751,278...102,800,520
Ensembl chr13:102,751,321...102,764,631

G

autophagy related 12

increases expression

methylparaben results in increased expression of ATG12 mRNA

NCBI chr18:39,452,247...39,462,424
Ensembl chr18:39,452,191...39,462,418

G

ATM serine/threonine kinase

decreases expression

methylparaben results in decreased expression of ATM mRNA

NCBI chr 8:53,828,741...53,932,773
Ensembl chr 8:53,831,093...53,932,437

G

atos homolog A

increases expression

methylparaben results in increased expression of ATOSA mRNA

NCBI chr 8:75,694,828...75,772,565
Ensembl chr 8:75,695,022...75,772,549

G

antioxidant 1 copper chaperone

decreases expression

methylparaben results in decreased expression of ATOX1 mRNA

NCBI chr10:39,564,855...39,579,892
Ensembl chr10:39,564,857...39,579,950

G

ATP synthase F1 subunit epsilon

decreases expression

methylparaben results in decreased expression of ATP5F1E mRNA

NCBI chr 3:163,259,072...163,261,974
Ensembl chr 3:163,260,476...163,261,450

G

ATP synthase inhibitory factor subunit 1

decreases expression

methylparaben results in decreased expression of ATP5IF1 mRNA

NCBI chr 5:144,738,950...144,742,668
Ensembl chr 5:144,738,950...144,742,668

G

ATP synthase membrane subunit c locus 1

decreases expression

methylparaben results in decreased expression of ATP5MC1 mRNA

NCBI chr10:81,024,056...81,026,780
Ensembl chr10:81,023,925...81,027,124
Ensembl chr10:81,023,925...81,027,124

G

ATP synthase membrane subunit c locus 3

increases expression
decreases expression

methylparaben results in increased expression of ATP5MC3 mRNA
methylparaben results in decreased expression of ATP5MC3 mRNA

NCBI chr 3:58,810,535...58,813,185
Ensembl chr 3:58,810,535...58,814,279

G

ATP synthase membrane subunit G

increases expression

methylparaben results in increased expression of ATP5MG mRNA

NCBI chr 8:45,225,680...45,233,630
Ensembl chr 8:45,225,686...45,233,559

G

ATR serine/threonine kinase

increases expression

methylparaben results in increased expression of ATR mRNA

NCBI chr 8:96,426,704...96,524,152
Ensembl chr 8:96,426,724...96,524,136

G

ATRX, chromatin remodeler

increases expression

methylparaben results in increased expression of ATRX mRNA

NCBI chr X:70,850,981...70,997,330
Ensembl chr X:70,850,981...70,997,330

G

apoptosis and caspase activation inhibitor

increases expression

methylparaben results in increased expression of AVEN mRNA

NCBI chr 3:99,299,009...99,431,635
Ensembl chr 3:99,298,930...99,431,634

G

Axl receptor tyrosine kinase

decreases expression

methylparaben results in decreased expression of AXL mRNA

NCBI chr 1:81,265,088...81,296,278
Ensembl chr 1:81,265,088...81,296,265

G

beta-2 microglobulin

increases expression

methylparaben results in increased expression of B2M mRNA

NCBI chr 3:109,095,740...109,101,764
Ensembl chr 3:109,095,729...109,101,766

G

BAG cochaperone 2

decreases expression

methylparaben results in decreased expression of BAG2 mRNA

NCBI chr 9:35,970,033...35,980,677
Ensembl chr 9:35,970,033...35,980,721

G

BAG cochaperone 3

decreases expression

methylparaben results in decreased expression of BAG3 mRNA

NCBI chr 1:183,103,038...183,126,862
Ensembl chr 1:183,102,871...183,126,858

G

BAR/IMD domain containing adaptor protein 2 like 1

decreases expression

methylparaben results in decreased expression of BAIAP2L1 mRNA

NCBI chr12:10,250,434...10,339,937
Ensembl chr12:10,250,473...10,339,928

G

BCL2 associated X, apoptosis regulator

increases expression

methylparaben results in increased expression of BAX mRNA

NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368

G

BCL2, apoptosis regulator

decreases expression

methylparaben results in decreased expression of BCL2 mRNA

NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743
Ensembl chr13:22,684,989...22,853,743

G

Bcl2-like 1

increases expression

methylparaben results in increased expression of BCL2L1 mRNA; methylparaben results in increased expression of BCL2L1 protein

NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479
Ensembl chr 1:141,253,523...141,303,479

G

Bcl2-like 11

increases expression

methylparaben results in increased expression of BCL2L11 mRNA

NCBI chr 3:115,366,783...115,404,068
Ensembl chr 3:115,366,646...115,404,068

G

Bcl2-like 2

increases expression

methylparaben results in increased expression of BCL2L2 mRNA

NCBI chr15:28,346,449...28,361,627
Ensembl chr15:28,356,807...28,361,624

G

bone gamma-carboxyglutamate protein

decreases expression
multiple interactions

methylparaben results in decreased expression of BGLAP mRNA
NR3C1 protein promotes the reaction [methylparaben results in decreased expression of BGLAP mRNA]; PPARG protein promotes the reaction [methylparaben results in decreased expression of BGLAP mRNA]

NCBI chr 2:173,838,518...173,839,495
Ensembl chr 2:173,838,518...173,839,495